TSS:Rfhg 37554.1

Basic information about the TSS

---

TSS ID: rfhg_37554.1 Species: human Chr: chr2		Start: 202376482 End: 202376499 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3232512,EH38E2066748)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000374580.10:-155 GeneID: 659 HGNC/MGI_ID: HGNC:1078 UniProt_ID: Q13873 Nearer transcript ids and distances:

Gene_name: BMPR2 Gene_symbol: BMPR2 Gene_synonyms: BMPR-II BMPR3 BRK-3 T-ALK Gene_source: HGNC:1078

TATA-Box annotation

---

Distance to TSS:	163
Nearest PromoterID:	NM_001204
Entrez ID:	659
Nearest Unigene:	Hs.471119
Nearest Refseq:	NM_001204
Nearest Ensembl:	ENSG00000204217
Gene Name:	BMPR2
Gene Alias:	BMPR-II|BMPR3|BMR2|BRK-3|POVD1|PPH1|T-ALK
Gene Type:	protein-coding
CpG%:	0.058824
GC%:	0.666667
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BMPR2 p2@BMPR2 p3@BMPR2 p4@BMPR2 p5@BMPR2 p6@BMPR2 p7@BMPR2 p10@BMPR2
Sample		p1@BMPR2	p2@BMPR2	p3@BMPR2	p4@BMPR2	p5@BMPR2	p6@BMPR2	p7@BMPR2	p10@BMPR2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	15.00	2.92	0.58	0.58	0.00	0.39	0.19	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	12.14	2.63	0.40	0.20	0.00	0.40	0.20	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.38	3.86	0.96	0.00	0.00	0.19	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	8.73	2.49	0.42	1.04	0.21	0.21	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	13.72	2.25	0.90	0.67	0.67	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	7.17	2.71	0.39	0.39	0.19	0.19	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.19	1.96	0.65	0.44	0.22	0.22	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	6.78	1.45	0.97	0.00	0.00	0.24	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.41	3.85	0.85	0.21	0.00	0.00	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.85	2.32	0.00	1.16	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	11.72	4.45	0.81	0.40	0.00	0.40	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	5.69	3.25	0.41	0.81	0.41	0.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	11.77	2.42	0.32	0.16	0.48	0.16	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	12.18	1.65	1.50	0.60	0.15	0.15	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	10.32	1.54	0.88	0.00	0.88	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.80	1.01	0.25	0.50	0.50	0.50	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	9.83	1.97	0.66	0.00	0.22	0.66	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	2.11	0.42	0.00	1.69	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.33	1.60	0.00	0.00	0.53	0.53	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	9.33	1.65	0.75	0.45	0.15	0.45	0.15	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.03	2.14	1.20	0.67	0.80	0.13	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	12.60	1.21	0.52	2.24	0.35	0.69	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	10.21	1.94	1.42	0.65	0.78	0.13	0.52	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	8.49	1.70	0.49	0.49	0.49	0.00	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.38	1.55	0.26	1.03	0.52	1.03	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	2.85	0.32	1.90	1.27	0.32	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	14.29	1.10	0.55	1.10	0.55	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.03	3.77	0.47	2.59	1.65	0.24	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.82	1.45	0.32	2.26	1.62	0.16	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	10.13	1.45	0.18	1.27	1.63	0.36	0.18	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.28	0.21	0.42	1.47	1.67	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	8.21	1.76	0.39	0.98	1.17	0.59	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.93	2.74	0.42	1.90	1.06	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.83	1.98	0.49	1.81	2.14	1.15	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.84	1.12	0.19	2.80	0.75	0.56	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.82	1.34	0.38	2.68	1.72	0.77	0.96	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.26	1.02	0.20	3.47	1.84	1.02	0.82	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.32	2.42	0.40	3.43	1.61	0.81	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.32	1.35	0.81	3.24	2.16	0.27	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.56	3.84	1.44	2.64	0.96	0.48	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.35	3.29	0.71	3.06	1.41	0.47	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	18.88	2.49	0.59	3.95	1.61	0.73	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	14.55	1.48	0.42	3.37	2.74	0.42	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.36	1.92	1.92	3.67	1.57	1.05	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.86	2.61	1.00	3.21	2.01	0.40	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.91	2.09	0.70	3.26	1.63	0.70	0.00	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	16.31	2.16	1.44	3.36	1.92	0.48	0.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.62	2.98	0.00	2.38	1.79	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	19.39	2.39	1.44	2.87	0.96	0.48	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.98	1.42	0.40	3.03	3.24	0.61	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.22	0.82	1.64	2.46	1.02	1.43	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	18.01	2.89	0.67	2.00	1.11	2.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	0.00	0.00	0.00	0.00	27.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.68	2.48	1.77	2.48	1.06	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	15.24	2.65	0.33	1.33	1.66	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	44.46	0.84	0.00	5.03	1.68	5.03	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	1.84	1.38	0.92	0.92	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	14.58	2.27	1.30	0.00	0.97	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.85	2.25	0.32	0.96	0.32	0.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.97	0.63	0.63	0.94	0.63	0.31	0.94	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	9.87	0.71	2.12	0.71	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.82	1.68	0.00	0.56	0.56	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	34.23	6.37	1.59	0.00	0.80	3.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	12.91	3.74	2.04	0.68	1.70	0.68	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.67	2.27	0.32	1.30	1.30	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.81	0.35	1.06	0.71	0.35	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	23.69	0.00	0.00	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	10.73	1.46	0.00	0.00	0.98	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	9.42	1.98	0.00	0.50	0.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	2.35	0.47	0.94	0.94	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.29	0.99	0.33	0.33	0.00	0.00	0.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	6.19	0.31	0.93	0.00	0.62	0.00	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.64	2.14	1.53	0.31	0.00	0.00	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	18.69	2.69	0.95	2.06	2.22	0.32	0.79	0.00
Adipocyte - breast, donor2	11327-117E4	11.87	2.89	1.28	0.80	0.96	0.32	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	18.32	3.44	1.78	2.29	2.29	0.64	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	12.71	2.24	0.00	0.75	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	11.39	3.68	0.33	0.00	1.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	2.55	2.55	1.28	0.64	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	1.10	0.00	1.10	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	2.71	1.35	0.45	0.00	0.00	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	4.52	0.87	0.35	0.00	0.00	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	19.95	3.32	2.54	0.59	0.20	0.59	0.98	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	13.90	3.86	1.54	0.00	0.51	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	12.27	3.90	2.23	0.28	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	18.22	4.11	1.18	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.53	2.33	1.53	0.56	0.88	0.48	0.16	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	17.11	5.16	1.94	0.32	0.32	0.65	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	2.13	0.53	1.60	0.53	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.69	3.90	0.00	0.00	0.56	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	2.50	0.00	0.42	0.83	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	9.80	2.76	0.75	0.25	0.75	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	10.14	1.31	1.31	0.65	0.65	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	7.31	2.74	0.00	0.91	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	6.41	1.10	1.10	0.44	0.44	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	1.43	0.72	0.36	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	15.11	5.76	1.80	0.18	0.54	0.54	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	3.35	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	3.70	0.62	0.82	0.21	0.41	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	12.70	4.58	1.49	0.23	0.00	0.11	0.23	0.23
Anulus Pulposus Cell, donor2	11463-119B5	7.10	1.96	1.47	0.73	0.98	0.00	0.98	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	9.44	2.25	1.35	0.00	0.45	0.00	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	1.74	0.43	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.27	2.09	0.30	0.30	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	1.26	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.98	0.66	0.00	1.32	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	4.22	0.00	1.95	0.00	0.00	0.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.31	2.91	0.49	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	0.59	0.00	0.00	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	0.38	1.13	1.13	0.38	0.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.98	1.45	0.73	0.00	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	0.00	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	10.71	1.98	0.33	1.15	0.16	0.33	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	6.82	0.00	0.00	0.00	4.09	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.73	1.06	0.30	0.15	0.00	0.15	0.30	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	7.50	1.61	1.61	0.00	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	7.18	1.70	0.19	0.19	0.00	0.19	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.95	1.60	0.27	0.53	0.53	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	0.98	0.98	0.98	1.95	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	6.97	1.66	0.50	0.66	0.00	0.00	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	2.40	1.20	0.00	1.20	2.40	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	3.54	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.69	1.54	0.51	0.34	0.34	0.17	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	2.43	0.49	0.00	0.49	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.31	1.90	0.00	0.00	1.52	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	2.42	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.27	1.71	0.57	0.57	0.57	0.00	1.14	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.27	1.07	1.07	0.21	0.64	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	5.16	1.03	0.00	0.26	0.00	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	1.88	0.94	0.00	1.41	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.72	1.29	0.64	0.32	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	5.71	2.14	0.71	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	7.60	0.58	0.58	0.00	0.58	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	7.23	0.90	0.30	0.00	0.00	0.00	0.00	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	0.00	1.19	0.00	0.00	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	5.59	0.51	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.15	1.53	0.00	0.25	0.51	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.08	0.64	0.00	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	10.79	3.02	0.43	0.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	6.14	0.64	0.64	0.42	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.48	0.58	0.87	0.00	0.00	0.58	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	4.72	2.83	0.94	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.46	2.20	0.17	0.17	0.00	0.00	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	4.23	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	7.50	1.29	0.43	0.43	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.81	0.60	0.60	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	0.73	0.73	0.73	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	8.51	2.07	0.69	1.38	0.23	0.46	0.23	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	7.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.05	0.76	0.25	1.02	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.99	1.45	1.45	0.00	0.21	0.21	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	3.98	3.37	0.00	0.00	0.00	0.00	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	6.21	2.39	0.48	0.48	0.00	0.48	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.77	2.00	0.44	0.00	0.44	0.44	0.22	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	1.66	0.00	0.55	1.66	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.83	1.32	0.00	0.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	1.82	0.36	0.00	0.00	0.00	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	8.72	3.81	0.49	0.86	0.25	0.00	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.39	3.08	1.03	0.51	0.17	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	6.29	1.26	0.63	0.00	0.21	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	33.46	4.53	0.70	0.35	0.70	0.00	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	22.49	5.82	1.29	0.49	0.16	0.65	0.32	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	33.11	5.37	1.94	1.19	1.04	0.30	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	8.37	7.34	3.10	0.69	0.46	0.23	0.11	0.57
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	7.39	5.39	1.13	0.50	0.25	0.13	0.38	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	8.19	5.92	2.05	0.57	0.23	0.00	0.34	0.34
Basophils, donor1	12241-129G9	2.62	4.45	0.26	0.52	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	3.61	3.97	1.80	0.00	0.36	0.00	0.36	0.36
Basophils, donor3	12243-129H2	4.56	4.56	1.62	0.44	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.68	0.65	0.22	0.00	0.00	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	4.57	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	6.90	3.14	0.63	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.69	0.42	0.00	0.21	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	5.99	0.23	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	6.48	1.26	0.18	0.00	0.18	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	4.53	2.47	0.62	0.10	0.21	0.00	0.31	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.19	2.10	0.23	0.23	0.00	0.00	0.23	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	3.52	2.24	0.00	0.32	0.32	0.64	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	10.34	0.00	0.00	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	1.69	2.82	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	3.71	3.90	0.93	0.00	0.00	0.00	0.56	0.19
CD14+ Monocytes, donor3	11381-118B4	4.17	4.39	1.10	0.66	0.00	0.22	0.44	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.11	5.38	2.55	0.28	2.26	1.70	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	12.51	5.31	2.27	0.76	0.76	0.00	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	22.68	2.96	2.96	1.31	0.66	1.64	0.66	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	12.00	4.05	1.45	0.43	0.29	0.29	0.29	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	12.67	2.11	1.21	0.00	0.30	1.21	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	13.03	3.79	1.90	0.47	0.00	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.53	1.51	1.34	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.49	2.48	0.55	0.00	0.28	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	8.18	2.23	0.74	0.25	0.00	0.00	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	9.01	4.31	0.98	0.00	0.20	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	11.93	1.42	1.42	0.36	0.18	0.36	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.84	2.39	1.31	0.44	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.51	2.58	0.70	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	1.06	1.58	0.00	0.00	0.00	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	7.77	0.00	1.11	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	7.59	2.53	1.49	0.30	0.15	0.30	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.58	2.39	1.80	0.80	0.00	0.60	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.24	1.67	1.87	0.83	0.00	0.00	0.21	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	12.35	2.29	2.29	0.00	0.23	0.69	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	12.44	3.85	2.71	0.23	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	8.73	0.44	0.87	0.44	0.44	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.91	4.57	1.34	0.81	0.00	0.54	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	18.49	2.09	2.27	0.35	0.52	0.00	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	17.25	5.47	1.68	0.42	0.42	0.00	0.84	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	11.02	2.76	1.10	0.18	0.18	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	8.45	2.82	1.76	0.35	0.00	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	10.53	1.75	1.32	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	13.78	3.49	2.27	0.35	0.00	0.17	0.17	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	12.64	2.60	0.74	0.74	0.00	0.74	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	14.87	3.66	1.51	0.65	0.22	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.88	3.28	1.23	0.41	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.13	2.09	0.70	0.93	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.83	3.48	1.62	0.93	0.23	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	1.31	1.53	1.09	0.00	0.00	0.00	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	3.70	2.54	0.92	0.00	0.00	0.23	0.46	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	1.52	3.68	0.65	0.43	0.22	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	6.85	3.58	1.71	0.16	0.16	0.31	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	9.78	2.97	0.87	0.35	0.17	0.17	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	9.81	4.46	2.23	0.67	0.00	0.45	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	0.77	3.83	0.77	0.00	0.00	0.00	0.77	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.54	4.17	0.88	0.00	0.00	0.00	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	3.16	2.74	0.63	0.00	0.00	0.00	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	2.03	6.10	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	1.36	6.10	0.00	0.00	0.00	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	1.04	6.21	0.00	0.00	0.00	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3.20	14.39	0.53	0.00	0.00	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.75	10.72	0.00	0.54	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	3.51	5.62	0.00	0.00	0.00	1.40	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.14	6.27	0.00	0.78	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1.32	5.27	1.32	1.32	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	2.47	9.86	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	1.45	12.33	0.00	0.00	0.00	0.00	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	1.51	11.11	1.51	0.00	0.00	0.00	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	10.51	6.87	2.42	0.00	0.40	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	7.59	3.99	0.40	0.40	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	5.02	4.02	1.00	1.00	0.00	0.00	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	3.37	5.06	0.00	0.56	1.12	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	2.25	1.50	0.00	0.00	0.38	0.38	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	3.16	1.58	0.45	0.00	0.23	0.23	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	3.21	12.50	1.07	0.71	0.36	0.00	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	2.45	12.86	0.00	0.00	0.00	0.00	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	3.35	9.45	0.61	0.91	0.00	0.30	0.91	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.28	5.87	0.51	0.00	0.00	0.00	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	0.67	5.39	0.45	0.22	0.22	0.22	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	0.57	7.76	0.00	0.29	0.00	0.00	0.86	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	9.96	0.00	0.00	0.00	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.70	6.32	0.00	0.00	0.70	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	9.89	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	2.89	9.97	0.87	0.00	0.00	0.14	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1.86	7.46	0.68	0.00	0.00	0.17	0.68	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	1.93	5.16	1.13	0.32	0.00	0.00	0.64	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	2.69	10.31	0.45	0.00	0.00	0.45	0.90	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.40	12.58	0.35	0.00	0.00	0.00	0.70	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.76	17.16	0.00	0.00	0.00	0.00	1.32	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	0.42	7.17	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	1.04	5.19	0.42	0.00	0.00	0.21	0.42	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	0.67	3.34	0.67	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.54	12.78	0.82	0.00	0.27	0.00	1.63	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1.07	9.11	0.00	0.00	0.00	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	17.93	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	1.11	5.75	0.74	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	1.30	6.93	0.65	0.00	0.00	0.22	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	1.05	5.88	0.84	0.00	0.00	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1.52	5.06	0.51	0.00	0.51	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	5.20	0.43	0.00	0.00	0.00	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.31	6.97	0.44	0.00	0.00	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1.98	9.40	1.98	0.49	0.00	0.00	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1.85	9.23	0.00	0.00	0.00	0.00	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	6.98	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	2.77	9.97	0.55	0.00	0.00	0.55	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	3.68	12.76	1.72	0.74	0.00	0.25	1.47	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	4.62	7.70	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	2.15	8.95	0.72	0.00	0.00	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	2.77	2.77	1.38	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	9.17	8.18	0.65	0.00	0.65	0.98	1.64	1.31
CD8+ T Cells, donor2	11307-117C2	6.38	13.89	0.38	0.00	0.00	0.38	1.13	0.00
CD8+ T Cells, donor3	11383-118B6	4.04	12.37	0.76	0.00	0.50	0.25	0.50	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.15	1.61	0.46	0.00	0.00	0.00	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.20	1.92	0.00	0.00	0.24	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.64	1.37	0.55	0.00	0.00	0.00	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	2.10	0.90	0.60	0.00	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	2.40	0.72	0.72	0.00	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.50	1.14	0.23	0.00	0.00	0.00	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	2.17	0.65	0.43	0.22	0.00	0.00	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.95	1.84	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	1.88	1.64	0.00	0.47	0.23	0.00	0.23	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.72	2.72	0.60	0.00	0.00	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	2.91	1.45	0.00	0.00	0.29	0.29	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	2.66	1.07	0.27	0.27	0.27	0.27	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	3.06	0.00	0.00	1.31	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	5.92	2.73	0.00	0.91	1.37	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	7.46	0.75	0.00	0.75	0.75	0.00	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	0.72	0.72	0.00	1.08	0.36	0.00	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.01	0.29	0.29	0.00	0.00	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.89	1.89	0.00	0.24	0.00	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.17	1.58	0.32	0.32	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.77	1.85	0.92	0.00	0.31	0.62	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	3.21	1.60	0.64	0.00	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	2.68	2.29	0.00	0.00	0.00	0.38	0.76	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.55	1.58	0.39	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	1.51	1.51	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	7.23	2.41	0.00	0.00	0.00	0.00	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.29	2.80	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	10.02	3.01	1.00	3.01	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	34.73	3.66	1.83	3.66	3.66	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	8.40	2.47	0.99	0.99	0.49	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	14.42	2.63	0.74	0.53	0.63	0.11	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	5.55	3.12	0.35	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	10.66	6.04	1.07	0.00	0.71	0.00	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	8.65	2.28	0.46	0.68	0.46	0.23	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	21.49	1.79	2.69	1.79	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	18.20	2.83	2.02	0.40	0.00	0.00	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	36.03	6.89	2.52	1.72	1.95	0.57	1.03	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	28.86	5.77	1.71	2.57	0.64	0.00	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	32.83	6.37	2.39	3.72	1.50	0.27	0.44	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	35.49	16.05	3.03	3.21	1.83	1.19	1.01	0.18
Corneal Epithelial Cells, donor1	11526-119I5	3.07	0.88	0.88	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	1.14	0.00	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	3.58	1.53	1.02	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	7.43	6.44	3.30	1.65	0.50	0.50	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	10.72	6.94	1.89	0.32	0.32	0.00	1.89	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	5.18	4.97	1.73	0.97	0.11	0.22	0.54	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	16.74	6.15	1.02	2.05	0.68	0.00	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	3.92	0.65	0.65	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.91	4.84	1.94	3.87	2.42	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	28.35	2.67	0.17	2.17	1.83	0.17	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	1.17	0.59	1.17	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	18.38	2.26	0.00	1.41	0.28	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	26.34	2.36	1.18	5.50	1.57	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.38	3.49	0.00	2.33	1.45	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	27.76	2.35	1.65	2.59	0.94	0.94	0.00	0.24
Endothelial Cells - Artery, donor3	11413-118E9	15.95	2.10	0.18	2.45	0.88	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	43.89	9.31	2.44	2.44	0.89	0.89	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	30.12	6.09	1.52	5.48	1.22	0.30	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	48.21	7.05	2.82	6.20	1.97	0.85	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	7.43	1.78	0.30	0.59	0.89	0.30	0.30	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	9.89	4.17	0.52	2.08	0.52	0.52	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	8.22	2.41	0.85	0.71	0.85	0.28	0.71	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	23.21	5.20	1.20	4.00	0.40	0.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	11.53	2.10	1.05	2.10	0.52	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	46.59	8.57	2.73	2.98	2.11	0.62	0.87	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.29	7.39	1.09	4.13	0.87	1.09	0.43	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.85	8.79	3.54	2.20	1.47	0.24	0.12	0.61
Endothelial Cells - Vein, donor1	11267-116G7	43.23	3.41	2.28	0.00	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	30.73	3.49	0.70	3.49	1.40	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	33.13	4.08	1.57	2.67	1.10	0.47	0.00	0.31
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	7.13	0.00	7.13	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.15	0.49	0.73	0.24	0.73	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.01	4.11	1.64	1.64	0.82	0.41	0.00	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.18	3.07	0.66	0.11	0.00	0.11	0.11	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	5.42	3.68	0.87	0.11	0.11	0.43	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	17.46	4.49	1.09	0.97	0.36	0.49	0.00	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	9.55	4.23	0.55	0.55	0.27	0.41	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.65	2.64	1.05	0.42	0.53	0.32	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.29	7.90	1.58	1.32	1.05	0.26	0.26	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.29	5.32	1.33	1.33	0.66	0.00	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	10.89	3.18	0.91	0.00	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.13	0.76	0.76	0.76	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.25	1.10	0.32	0.47	0.32	0.00	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	14.55	7.27	1.82	0.61	0.61	0.00	0.61	0.00
Fibroblast - Cardiac, donor5	11456-119A7	18.02	5.58	1.27	1.14	0.25	0.25	0.13	0.13
Fibroblast - Cardiac, donor6	11460-119B2	17.43	3.49	0.45	2.12	0.76	0.30	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.47	3.89	1.34	0.80	0.94	0.27	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	28.04	4.75	3.45	5.18	1.73	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	0.00	1.46	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	7.15	1.38	0.69	0.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	17.64	3.22	1.36	0.34	0.51	0.17	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	3.29	1.64	0.23	0.23	0.47	0.23	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	4.25	1.42	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	4.23	1.69	0.60	0.36	0.24	0.24	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	8.93	2.37	0.34	0.34	0.23	0.00	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	11.34	2.97	1.05	0.17	0.17	0.35	0.70	0.00
Fibroblast - Dermal, donor6	11458-119A9	8.28	1.46	0.65	0.65	0.00	0.00	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	14.58	3.12	1.25	0.62	0.62	0.21	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	30.92	5.50	1.05	2.88	0.26	0.26	0.26	0.52
Fibroblast - Gingival, donor2	11318-117D4	11.86	4.61	0.53	0.13	0.66	0.40	0.13	0.13
Fibroblast - Gingival, donor3	11394-118C8	17.98	3.48	1.26	0.97	0.68	0.19	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	8.31	3.12	1.04	0.00	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	17.44	5.11	1.23	0.53	0.53	0.70	0.53	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	22.29	3.74	1.56	1.09	1.25	0.16	0.78	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	11.22	3.25	1.35	1.08	0.81	0.14	0.54	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	26.82	7.41	4.23	1.76	1.06	0.00	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	16.23	3.07	0.88	0.73	0.73	0.15	0.29	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	17.86	3.68	1.91	0.68	0.95	0.14	0.41	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	15.03	3.29	0.77	1.32	1.43	0.00	0.22	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.15	6.16	1.03	0.88	1.17	0.88	0.29	0.29
Fibroblast - Lung, donor1	11270-116H1	8.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	4.48	0.00	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	6.33	2.32	1.90	0.42	0.21	0.21	0.00	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	10.00	3.33	0.00	0.00	0.83	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	0.00	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	0.56	0.56	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	13.80	3.25	0.81	0.41	0.00	0.00	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.55	4.46	0.39	0.19	0.39	0.19	0.58	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	16.84	4.25	1.06	0.46	0.30	0.46	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	20.81	3.06	1.53	1.53	0.61	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.36	3.82	1.14	1.14	1.91	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	12.15	2.70	0.54	0.27	0.81	0.27	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.77	3.25	1.51	0.35	0.70	0.35	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	10.94	2.65	0.66	0.99	0.22	0.22	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	7.31	2.24	0.61	0.20	0.41	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	5.35	1.34	1.34	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	5.54	0.40	0.00	0.40	0.40	0.00	0.79	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.59	6.95	2.18	2.58	2.38	0.20	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.52	4.80	1.95	0.53	1.07	0.71	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.37	8.08	1.38	0.39	0.59	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	23.17	6.02	3.31	2.11	1.50	0.30	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	19.97	6.69	0.86	0.65	0.76	0.32	0.32	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.67	5.31	0.51	0.76	0.51	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	16.90	5.25	1.48	0.66	1.48	0.66	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.07	6.22	3.61	3.41	2.41	0.40	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	19.99	4.22	1.00	2.61	1.61	0.40	0.20	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	16.62	4.53	2.12	1.21	1.51	0.30	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	21.21	7.37	1.91	0.91	0.50	0.25	0.66	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	17.10	7.01	1.54	1.20	0.85	0.34	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	21.68	7.23	0.99	1.31	1.97	0.00	0.66	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.43	4.05	1.60	1.38	1.07	0.64	0.43	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	13.33	3.88	0.51	0.84	0.51	0.34	0.34	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	13.80	2.51	0.47	0.63	1.10	0.63	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	17.43	6.97	3.49	0.87	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	21.67	4.68	0.87	1.21	0.87	0.52	0.00	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.94	2.60	1.04	1.04	0.78	0.52	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	18.65	1.28	1.02	3.32	1.02	0.00	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	7.66	6.12	0.00	0.77	0.00	0.77	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	3.19	1.28	0.00	1.28	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	8.27	6.56	0.29	0.29	0.00	0.29	0.86	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.79	2.76	0.83	0.28	0.28	1.10	0.28	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.96	6.16	2.74	0.91	0.00	0.46	1.83	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.12	6.14	0.20	0.20	0.20	0.40	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	6.34	2.64	0.00	0.00	0.26	0.26	1.59	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.11	4.89	0.98	0.65	0.33	0.33	0.65	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	1.33	2.21	0.00	0.00	0.00	0.44	0.88	2.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	8.34	2.54	1.13	0.00	0.42	0.28	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	8.62	4.56	1.48	0.25	0.25	0.62	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.91	1.88	1.07	0.00	0.27	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	10.28	2.85	0.62	0.50	0.50	0.12	0.62	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	7.61	2.49	0.28	0.28	0.14	0.14	0.42	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	7.32	2.24	0.61	0.20	0.20	0.20	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.15	2.74	0.91	0.23	0.46	0.46	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	10.34	2.62	1.00	0.25	0.12	0.25	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.77	4.59	0.22	0.44	0.44	0.22	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	8.57	2.07	0.59	0.89	0.00	0.59	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	10.01	5.09	0.64	0.48	0.32	0.16	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	14.75	3.80	1.12	0.00	0.22	0.22	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	9.88	2.42	0.60	0.00	0.40	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.04	3.73	1.02	0.17	0.17	0.34	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	18.00	5.05	1.06	0.27	0.80	0.62	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	23.31	3.23	1.66	0.62	0.52	0.42	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.42	3.07	1.37	0.34	0.17	0.17	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	18.04	3.76	1.11	0.44	0.22	0.11	0.44	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.39	4.24	1.33	0.58	0.17	0.42	0.08	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	13.07	3.88	2.25	0.20	0.00	0.41	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.62	3.71	0.41	0.00	0.00	0.41	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	14.64	4.04	1.15	0.12	0.46	0.35	0.12	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	14.01	3.67	1.00	0.17	0.17	0.17	0.33	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.23	3.31	1.32	0.22	0.22	0.66	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.13	5.17	1.72	0.25	0.12	0.00	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	13.78	6.16	1.13	0.81	0.49	0.00	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	19.24	4.17	0.64	0.96	0.64	0.32	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	18.38	5.78	1.71	0.28	0.28	0.57	0.47	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.60	4.43	0.63	0.32	0.32	0.16	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.12	7.30	0.61	0.61	0.61	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.13	5.23	1.67	0.31	0.63	0.00	0.94	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.91	4.83	2.63	0.22	0.44	0.00	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.96	4.77	0.00	1.12	0.00	0.28	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	33.79	6.85	2.78	0.93	0.93	0.83	0.19	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	16.31	7.22	0.80	0.27	0.00	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.86	5.97	1.84	1.22	0.31	0.61	0.31	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	25.78	5.18	1.04	2.20	0.78	0.52	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	25.21	6.51	1.63	0.54	0.27	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.55	5.90	1.11	1.11	0.92	0.00	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	32.02	4.82	1.97	0.66	0.66	0.44	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	59.50	10.91	1.98	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.58	4.75	1.06	0.66	0.66	0.53	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	27.04	4.44	2.42	0.81	0.40	0.40	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	66.59	6.35	3.81	1.02	1.27	1.02	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	9.75	4.18	1.39	0.40	0.00	0.20	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	9.55	4.78	1.39	0.46	0.31	0.31	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	11.25	5.52	1.23	0.00	0.00	0.00	0.61	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.13	3.13	0.00	0.00	0.00	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.26	2.26	0.00	0.00	0.28	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.61	5.53	0.92	0.92	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	0.00	0.00	0.00	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	7.35	4.25	0.00	0.77	0.77	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	11.23	0.00	0.00	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	8.69	1.74	0.00	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.86	4.56	0.33	0.65	0.00	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	12.77	9.06	2.06	0.41	0.00	0.41	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	3.33	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.63	5.59	0.28	0.00	0.56	0.56	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.50	1.96	0.00	0.33	0.33	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	3.36	0.84	0.00	0.00	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	11.77	5.73	0.95	0.00	0.32	0.32	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.49	3.06	0.34	0.68	0.00	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	2.09	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.88	1.15	1.15	0.57	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	4.74	0.89	0.89	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	5.08	0.00	0.00	0.00	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	9.94	2.90	1.24	0.00	0.41	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	6.67	2.99	0.00	0.23	0.46	0.23	0.23	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	6.92	2.31	0.77	0.00	0.38	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.82	3.26	0.98	0.00	0.33	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	4.01	2.01	2.68	0.00	0.67	0.00	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.25	3.47	0.00	0.39	0.39	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	14.72	4.45	0.68	0.34	0.68	0.68	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	2.48	4.97	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	10.38	2.83	1.42	0.47	0.00	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	11.47	2.41	0.60	0.00	0.00	0.00	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	11.70	3.05	1.02	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	15.95	1.60	0.40	0.00	0.40	1.60	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	14.80	2.96	2.47	0.00	0.99	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	1.18	0.00	0.00	1.18	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	11.09	2.92	2.33	0.00	0.00	0.58	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	15.36	4.39	1.32	0.88	0.00	0.00	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	1.70	2.54	1.70	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	20.30	2.39	0.60	0.00	0.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	7.76	2.91	0.49	0.49	0.00	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	7.99	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	7.48	3.33	0.00	0.42	0.42	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	12.37	2.25	0.00	1.12	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.98	1.59	0.63	0.00	0.00	0.00	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	1.67	0.84	0.00	0.00	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	3.60	0.46	0.46	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	2.53	0.51	0.17	0.51	0.17	0.00	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	4.10	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	4.26	0.55	0.22	0.11	0.11	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	3.44	0.21	0.21	0.00	0.00	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	3.01	0.65	0.22	0.00	0.00	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.24	0.75	0.25	0.12	0.00	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.92	0.34	0.51	0.00	0.34	0.00	0.17	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	3.20	0.00	0.00	0.00	0.32	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	5.60	1.68	1.68	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.36	1.30	0.87	0.00	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	5.29	0.00	0.00	0.00	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.29	2.82	0.71	0.71	0.71	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	8.72	2.18	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.52	1.22	0.52	0.00	0.17	0.00	0.00	0.00
Hepatocyte, donor1	11523-119I2	20.58	2.42	1.21	1.21	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	24.78	2.15	4.31	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	32.52	6.75	1.23	4.91	2.45	1.84	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	3.92	0.00	0.00	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	17.83	3.67	1.05	0.35	0.17	0.17	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.94	3.70	1.51	0.82	0.55	0.41	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	0.00	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	3.97	0.00	0.00	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	2.22	1.11	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.26	1.26	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	1.55	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	3.23	0.00	0.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	0.81	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	0.42	0.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	1.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	0.00	0.91	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	1.82	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.14	1.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	0.31	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.00	2.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	2.62	0.00	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	3.20	0.00	0.00	1.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	1.39	0.00	0.00	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.44	1.22	0.98	0.73	0.90	0.16	0.00	0.08
Keratinocyte - epidermal, donor2	11349-117G8	3.51	0.59	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	6.72	0.66	0.38	0.19	0.28	0.00	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	18.50	3.75	1.36	0.68	0.68	0.00	0.45	0.11
Keratocytes, donor1	11527-119I6	7.91	1.72	0.00	0.34	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	2.34	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	15.61	5.93	1.78	0.59	0.40	0.40	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	2.20	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	8.63	2.16	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	16.61	2.31	0.81	0.69	0.35	0.12	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	32.69	5.35	2.42	3.63	2.02	0.00	0.50	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.25	4.15	1.07	2.49	0.83	0.36	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.56	2.23	0.84	1.40	0.56	0.84	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.32	7.56	1.73	2.36	1.89	0.47	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	6.99	4.84	0.54	1.08	1.08	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	2.84	0.00	0.00	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.37	2.37	0.65	1.08	0.54	0.54	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	21.34	4.51	0.00	1.23	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.60	2.28	0.51	0.76	0.00	0.51	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.22	3.66	0.70	1.69	0.84	0.00	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.10	3.16	0.79	2.77	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	11.05	2.91	0.58	0.78	0.19	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	8.15	2.41	0.56	0.93	0.74	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	11.15	4.88	0.35	2.09	1.74	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.78	2.15	1.19	0.95	0.72	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.61	2.61	0.41	0.41	0.69	0.27	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.63	2.46	1.23	1.23	1.23	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.86	1.25	0.00	0.31	0.94	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	13.72	3.48	0.73	1.46	1.28	0.18	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.08	2.96	0.33	3.62	0.99	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.91	0.59	0.29	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.46	1.00	1.00	0.25	0.50	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	18.43	3.88	1.45	0.97	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.69	2.42	0.27	1.08	0.27	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.65	3.33	0.45	1.21	1.06	0.30	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.22	3.63	0.00	0.52	0.52	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.54	4.61	1.47	1.68	0.42	0.63	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.68	2.86	0.75	0.75	0.30	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	12.38	3.44	1.38	2.06	0.00	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	10.16	1.32	0.19	0.75	0.56	0.00	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	11.35	2.23	0.42	1.06	0.85	0.11	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.51	3.39	0.48	0.48	0.00	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.60	1.65	0.66	0.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.56	4.21	0.50	1.24	0.50	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	32.21	4.44	0.74	2.22	0.37	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	8.40	2.72	0.00	0.99	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.76	3.16	0.55	0.55	0.69	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	16.40	5.47	1.29	1.29	2.89	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	15.22	4.26	0.91	0.91	0.91	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.76	4.48	1.12	1.96	1.12	0.14	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	13.87	2.13	0.71	1.42	2.13	0.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.85	0.97	0.00	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.62	1.40	0.16	0.31	0.16	0.16	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.18	1.43	1.43	0.72	1.43	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.51	2.61	0.33	0.65	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.36	1.65	0.24	0.24	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.36	3.71	1.49	1.73	0.62	0.37	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	6.15	1.79	0.51	0.51	0.26	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	8.95	2.09	0.00	1.49	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	0.00	4.53	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	8.44	6.90	1.53	0.00	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	7.42	5.20	0.00	0.00	1.48	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	11.85	4.23	0.42	0.85	0.42	0.00	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	3.52	1.41	0.70	0.70	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	9.34	2.80	0.93	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	11.85	4.12	0.52	0.00	1.03	0.00	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	11.89	1.19	1.19	1.19	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.12	7.46	0.23	1.13	0.23	0.00	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.76	3.20	0.58	0.87	0.29	0.58	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	12.15	4.95	0.90	0.45	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.23	6.10	1.76	0.95	0.68	0.14	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.30	3.59	0.51	1.03	0.51	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.94	6.35	0.71	0.35	0.00	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.66	2.67	0.67	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.66	2.04	1.02	0.51	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	5.87	1.33	0.53	0.80	0.27	0.00	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.79	5.29	1.32	0.38	0.57	0.19	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.04	8.59	0.00	0.00	0.00	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	4.89	2.45	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	17.28	5.00	1.25	0.62	0.21	0.21	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	13.17	3.08	0.84	0.56	0.28	0.84	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	11.33	3.09	1.03	0.00	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	14.52	4.94	1.45	1.74	0.87	0.58	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.16	5.08	0.60	0.90	0.60	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	4.43	0.55	1.11	0.55	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	14.49	3.53	1.41	0.00	1.06	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.74	4.79	0.74	0.74	0.37	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	9.21	4.61	2.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	9.21	5.37	1.15	0.38	0.00	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.06	5.10	0.00	0.00	2.26	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	6.56	1.64	1.64	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	4.52	0.45	1.81	0.45	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	7.18	1.44	0.00	0.72	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	9.71	2.24	1.49	0.00	0.75	0.75	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.01	5.57	1.11	0.37	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	9.05	5.60	1.29	0.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	0.86	0.86	0.86	0.86	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.33	5.00	0.33	0.33	0.33	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	3.62	0.00	0.60	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	16.35	4.98	0.71	2.13	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	11.34	3.44	1.03	1.03	0.00	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	3.22	0.54	0.54	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	9.43	7.41	0.67	2.02	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	8.15	5.56	0.37	1.11	1.11	0.00	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	11.63	6.98	1.16	2.33	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	19.04	3.17	0.00	2.12	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.01	7.60	3.20	0.80	0.40	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	11.63	7.27	0.73	0.73	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.16	5.37	2.30	0.77	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	2.96	0.99	1.48	0.00	0.49	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	6.59	5.65	3.76	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	13.07	7.54	1.01	1.01	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	13.07	5.41	2.25	1.35	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	13.77	5.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.58	4.01	0.89	0.89	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	12.90	7.82	3.13	1.96	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	5.94	1.32	1.32	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.01	8.30	2.59	1.56	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.69	4.81	0.44	0.00	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	12.86	2.80	1.68	0.00	1.12	0.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	9.72	5.74	1.32	0.44	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	11.57	5.79	1.93	2.70	0.39	0.39	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	10.13	3.04	1.52	0.51	1.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.02	4.81	1.92	0.00	0.48	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	15.11	6.76	2.39	0.80	0.40	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.29	7.29	1.22	0.61	1.22	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	3.46	2.08	0.00	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	17.10	6.84	1.52	0.38	0.38	0.38	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	8.26	1.03	0.52	1.03	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	4.84	1.81	0.60	0.00	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.09	4.75	0.95	1.90	0.00	0.32	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.60	9.06	2.67	1.07	0.53	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	10.92	2.30	0.00	0.57	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	16.46	6.17	2.06	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	9.90	5.66	2.12	0.71	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.08	3.40	0.00	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.57	4.99	2.91	1.66	0.42	0.42	1.25	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	7.83	3.13	0.78	0.78	0.78	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	10.44	5.01	2.09	0.42	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.97	6.50	2.32	0.46	0.93	0.46	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	3.35	7.36	2.01	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	11.23	1.07	0.00	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	11.72	6.47	0.81	1.21	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	7.34	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	10.67	7.11	3.56	1.78	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.26	7.98	0.57	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	4.60	0.00	0.00	0.77	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	7.66	7.66	1.09	1.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	7.57	5.79	1.78	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.66	3.90	1.56	1.04	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	12.60	6.63	1.33	0.00	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	10.26	3.19	2.73	0.68	0.46	0.00	1.14	0.23
Macrophage - monocyte derived, donor2	11313-117C8	5.51	3.67	1.28	0.18	0.37	0.18	0.73	0.18
Macrophage - monocyte derived, donor3	11389-118C3	8.91	3.41	1.44	1.70	0.39	0.13	0.39	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	6.90	1.59	1.59	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	25.83	3.01	1.27	1.74	1.90	0.63	0.00	0.16
Mallassez-derived cells, donor3	11930-125I4	15.01	2.64	0.42	1.25	0.83	0.14	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	14.15	1.20	0.50	0.70	0.80	0.00	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	10.13	2.32	0.87	0.58	0.58	0.58	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	6.73	0.50	0.50	0.25	0.75	0.00	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	20.34	2.03	2.03	1.36	0.00	2.71	0.00	0.00
Mast cell, donor1	11563-120D6	15.14	5.52	1.30	0.65	0.32	1.08	0.22	0.11
Mast cell, donor2	11565-120D8	16.94	15.75	2.08	0.89	1.78	1.78	1.19	0.59
Mast cell, donor3	11566-120D9	20.94	9.68	3.15	1.80	1.80	1.80	0.23	0.68
Mast cell, donor4	11567-120E1	20.74	7.62	3.01	3.19	1.95	1.60	0.71	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	10.53	6.43	1.11	0.67	0.00	0.55	0.33	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	58.95	3.50	2.33	6.42	4.09	3.50	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	16.86	9.06	1.95	0.23	0.11	1.38	0.57	0.11
Mast cell, expanded, donor8	11941-126A6	25.11	5.69	2.51	1.84	1.51	2.34	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	19.60	6.27	1.09	1.99	0.50	0.30	0.40	0.10
Melanocyte - dark, donor2	11582-120F7	11.07	2.08	1.73	0.35	0.35	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	22.02	6.59	1.67	0.51	0.43	0.07	0.36	0.00
Melanocyte - light, donor1	11274-116H5	15.51	3.76	1.88	0.00	0.24	0.94	0.24	0.00
Melanocyte - light, donor2	11351-117H1	16.38	2.73	0.68	1.36	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	6.07	1.73	2.60	1.73	0.00	0.00	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	6.56	3.23	0.73	0.31	0.42	0.62	0.62	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	8.34	4.30	1.34	0.27	0.00	0.27	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	18.48	4.82	2.14	0.80	0.00	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	9.68	4.22	0.50	0.62	0.25	0.00	0.50	0.12
Meningeal Cells, donor2	11573-120E7	13.20	3.96	0.88	0.44	0.00	0.00	0.44	0.44
Meningeal Cells, donor3	11654-122E7	9.86	4.97	0.98	0.49	0.08	0.16	0.41	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	9.98	2.00	1.14	0.86	0.00	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	30.39	3.52	1.21	2.72	3.02	0.60	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	5.26	0.00	0.00	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	4.31	2.87	0.72	0.00	0.00	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	14.19	4.87	1.48	1.06	1.27	1.48	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	1.51	1.01	0.50	0.00	1.01	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.61	2.42	0.44	0.44	0.00	0.00	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	2.19	2.19	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	6.14	3.48	0.41	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	8.86	3.74	1.25	0.28	0.14	0.00	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	5.58	1.12	0.00	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.39	2.63	1.32	2.37	0.79	0.13	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.75	0.89	0.59	0.00	0.30	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	4.48	3.84	0.64	0.00	0.00	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	10.99	0.71	1.42	0.71	0.00	0.00	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	20.01	2.81	0.94	2.50	1.88	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.18	0.73	0.00	1.45	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	7.42	3.71	0.80	1.06	0.27	0.27	0.53	0.27
Mesothelial Cells, donor2	12156-128G5	5.51	5.00	0.00	0.00	0.50	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	10.84	4.55	1.23	0.87	0.07	0.14	0.36	0.36
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	6.75	2.70	0.00	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	8.87	3.69	1.97	0.49	0.49	0.74	1.23	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	5.01	0.59	0.29	0.29	0.29	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	3.46	0.00	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	6.82	1.86	1.55	0.62	0.00	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	5.60	1.87	0.41	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.51	1.50	0.75	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	3.72	2.33	0.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	6.50	3.45	2.44	0.20	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.52	5.15	1.58	0.40	0.00	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	4.42	0.00	0.88	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.56	1.52	0.38	0.38	0.00	0.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	5.26	0.00	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	0.85	0.85	0.21	0.42	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	2.76	1.84	0.92	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.24	2.09	1.49	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	5.77	0.50	1.51	0.25	0.50	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.47	2.38	2.14	0.48	0.24	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	12.16	4.42	0.00	1.66	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.37	1.15	0.92	0.69	0.23	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	6.31	2.52	1.05	0.42	0.00	0.21	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.60	2.65	1.22	0.41	0.61	0.00	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.23	1.93	0.86	0.21	0.86	0.43	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.00	6.00	1.33	0.89	0.22	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.54	1.53	0.66	1.31	0.22	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	5.58	2.53	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	1.66	3.31	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.57	3.26	1.09	2.99	0.54	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.18	5.88	1.18	1.18	1.18	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	6.54	2.18	4.36	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.94	5.29	1.44	0.96	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.41	5.60	2.80	1.60	0.80	0.40	1.20	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	19.20	4.11	1.37	2.74	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	3.50	2.00	2.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	10.19	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	2.19	1.31	0.88	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	26.49	6.62	0.00	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.93	8.97	2.56	4.48	1.28	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	14.88	4.96	2.23	0.99	0.99	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	2.09	0.00	1.39	3.48	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	41.99	11.05	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.94	1.71	1.03	1.37	0.34	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	17.07	3.50	1.75	1.75	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	4.26	1.42	2.84	1.42	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.91	2.81	1.40	1.68	0.28	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	20.78	3.74	1.66	4.57	1.66	0.00	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.99	5.24	1.17	1.75	1.17	0.58	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	15.99	2.11	2.11	2.11	1.81	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.53	4.17	2.09	2.09	1.67	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	7.22	0.00	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	7.39	3.69	0.92	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	5.69	2.28	1.14	0.57	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.71	3.04	1.11	1.24	0.69	0.28	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	2.33	1.04	0.78	0.52	0.00	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	17.16	4.72	1.72	0.86	0.43	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	16.51	5.08	0.64	2.54	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.81	5.07	1.60	0.80	1.07	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.57	5.09	1.20	0.90	0.00	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	8.48	3.39	0.99	1.41	0.57	0.14	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.51	5.10	0.32	1.27	0.64	0.32	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	14.59	3.10	1.99	2.43	0.66	0.00	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	5.31	0.38	1.14	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.50	6.82	1.99	0.00	0.85	0.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.29	3.44	1.97	0.98	0.49	0.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	3.26	1.96	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.29	4.12	0.88	1.18	0.00	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	10.09	3.75	1.15	1.15	1.15	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	7.83	3.30	2.06	0.00	0.41	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.02	6.25	1.49	0.60	0.60	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.57	0.33	0.66	0.00	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	5.26	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.33	0.99	0.79	0.59	0.40	0.00	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	2.79	0.00	0.00	0.00	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	4.51	0.38	0.00	1.13	0.75	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	3.46	0.80	0.80	0.00	0.27	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.82	1.47	1.47	0.45	0.00	0.00	0.23	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	0.74	1.47	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	5.13	1.47	0.00	0.73	0.37	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	1.56	1.56	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	7.48	1.60	2.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	4.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.06	1.69	0.42	0.42	0.42	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	1.36	1.36	13.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	1.27	0.64	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.91	0.00	0.81	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	1.51	0.00	3.02	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	79.94	11.42	11.42	57.10	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	3.26	3.26	6.52	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	14.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	0.00	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	12.71	4.31	1.08	0.65	0.86	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.59	4.18	0.52	1.05	0.52	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	5.34	1.33	0.00	0.00	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	3.76	4.17	0.00	0.83	1.25	0.00	0.42	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	9.51	4.94	1.52	0.19	0.00	0.00	0.00	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	9.58	6.38	1.60	1.60	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	4.08	0.00	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	16.54	5.51	0.00	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	4.60	1.67	0.84	0.00	0.42	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	3.25	3.49	0.93	0.23	0.70	0.46	0.00	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.92	2.70	1.08	0.00	0.00	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.98	3.15	1.68	0.42	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	4.96	4.47	1.49	0.00	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	3.25	1.89	0.54	0.00	0.27	0.27	0.81	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.99	2.49	0.45	0.00	0.00	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.19	4.74	1.47	0.00	0.33	0.16	0.16	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	8.75	2.92	0.73	0.55	0.18	0.55	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	3.18	1.59	0.53	0.00	1.06	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	4.20	1.20	0.00	0.00	0.00	1.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	5.91	4.92	1.31	0.66	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.74	3.58	2.60	0.00	0.16	0.00	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	13.23	4.23	1.23	0.88	0.18	0.18	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.92	3.52	0.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	1.84	6.44	1.38	0.00	0.00	0.00	0.46	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	2.25	1.61	0.32	0.32	0.00	1.93	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	10.35	3.45	0.69	0.34	0.69	1.38	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	96.08	20.23	0.00	0.00	0.00	0.00	0.00	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.58	4.01	0.89	1.11	0.89	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	2.96	2.54	0.42	0.00	0.00	0.00	0.85	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.98	4.03	0.71	0.00	0.24	0.24	0.71	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	4.72	2.15	0.00	0.43	0.43	0.86	1.29
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	0.00	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.66	4.00	0.67	0.67	0.00	0.67	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	2.71	0.90	1.35	0.90	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	0.79	1.59	0.00	0.40	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	4.64	0.93	0.00	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.19	2.65	0.76	0.38	0.38	0.00	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	7.17	2.28	1.30	0.00	0.00	0.00	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	3.05	2.18	0.44	0.44	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	7.69	2.71	0.45	1.36	0.45	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	10.58	2.65	0.00	0.00	0.88	0.00	0.88	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.32	3.99	2.66	0.66	0.00	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	3.47	3.47	1.49	0.50	0.00	0.00	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	4.59	0.77	0.38	0.38	0.00	0.77	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	9.98	6.35	1.21	0.30	0.30	0.00	1.21	3.33
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	19.23	4.20	0.88	0.88	1.33	0.66	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	0.68	0.00	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	51.10	5.11	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	5.49	4.88	0.61	0.61	0.00	1.22	0.00	3.05
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	6.61	4.09	0.94	0.31	0.63	0.00	0.63	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.15	4.24	1.82	0.30	0.00	0.30	0.61	1.21
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	10.28	1.58	0.00	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	9.07	0.00	1.13	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.07	2.11	0.87	1.37	0.50	0.00	0.50	0.25
Myoblast, donor2	11322-117D8	12.66	4.41	0.19	0.77	0.58	0.00	0.38	0.00
Myoblast, donor3	11398-118D3	14.63	4.88	0.50	1.51	1.51	0.67	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.29	1.61	0.15	0.00	0.00	0.00	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	5.23	12.92	1.85	0.31	0.00	0.00	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	3.02	12.97	0.30	0.00	0.00	0.90	1.81	1.81
Natural Killer Cells, donor3	11387-118C1	2.94	15.46	0.74	0.74	0.00	0.18	0.92	1.66
Neural stem cells, donor1	11275-116H6	35.93	8.35	2.90	0.73	1.45	0.73	0.00	0.00
Neural stem cells, donor2	11352-117H2	50.07	17.33	1.93	0.00	1.93	0.00	0.00	0.00
Neurons, donor1	11494-119E9	35.27	2.28	1.14	1.14	1.14	2.28	0.00	0.00
Neurons, donor2	11574-120E8	40.51	8.15	1.54	0.44	0.22	0.66	0.00	0.88
Neurons, donor3	11655-122E8	23.02	5.76	3.29	2.47	0.82	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.00	2.78	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	8.55	0.61	0.00	0.00	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	21.13	4.99	1.78	0.36	0.59	0.12	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	6.84	0.98	0.98	0.33	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	5.82	2.61	0.20	0.40	0.20	0.20	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	10.05	5.09	1.38	0.69	0.55	0.28	0.00	0.55
Olfactory epithelial cells, donor2	11934-125I8	6.80	2.46	0.43	0.87	0.29	0.72	0.29	0.00
Olfactory epithelial cells, donor3	11935-125I9	10.33	3.63	1.02	0.45	0.00	0.00	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	19.97	5.55	1.36	1.27	0.39	0.39	0.68	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	29.49	5.42	0.60	1.81	1.81	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	7.02	2.13	0.43	0.00	0.00	0.21	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	3.43	1.14	0.00	0.00	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	1.86	0.62	0.62	1.24	0.00	0.62	0.00	0.62
Osteoblast, donor1	11277-116H8	5.47	0.59	0.59	0.00	0.39	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	15.45	4.92	2.11	0.70	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	14.22	3.02	0.89	0.36	0.71	0.36	0.18	0.71
Pancreatic stromal cells, donor1	11249-116E7	12.64	4.63	1.43	0.59	0.25	0.42	0.17	0.17
Pericytes, donor1	11491-119E6	3.78	1.11	0.67	0.11	0.56	0.00	0.22	0.00
Pericytes, donor2	11571-120E5	2.26	0.45	0.45	0.23	0.00	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	5.70	4.07	0.00	1.02	0.20	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	12.88	5.54	1.24	0.45	0.34	0.34	0.11	0.00
Perineurial Cells, donor2	11579-120F4	14.08	3.86	1.47	0.64	0.64	0.28	0.46	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	5.42	11.79	2.87	0.32	0.00	0.64	0.64	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	2.94	4.65	0.73	0.24	0.00	0.00	0.49	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	5.44	8.15	0.78	0.26	0.26	0.13	0.26	0.52
Placental Epithelial Cells, donor1	11278-116H9	6.22	0.96	0.72	0.00	0.24	0.24	0.00	0.48
Placental Epithelial Cells, donor2	11355-117H5	5.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.71	0.98	0.00	0.20	0.20	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	15.82	3.80	1.58	0.63	0.95	0.32	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	13.69	3.00	1.88	1.31	1.50	0.75	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	22.06	3.13	1.17	3.65	2.48	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	14.41	2.48	1.58	2.25	0.90	0.00	0.00	0.45
Preadipocyte - omental, donor1	11468-119C1	15.66	3.41	1.39	1.81	1.49	0.32	0.11	0.11
Preadipocyte - omental, donor2	11329-117E6	17.46	3.06	1.31	2.18	2.18	0.00	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	16.62	3.29	0.86	2.01	1.86	0.14	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	3.94	1.97	0.00	0.98	1.97	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.58	0.31	0.61	2.46	0.61	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	10.09	3.19	1.06	0.71	0.53	0.35	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	10.22	2.04	0.17	1.19	0.51	0.68	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	12.57	4.84	1.58	0.84	0.47	0.28	0.65	0.28
Preadipocyte - visceral, donor2	11357-117H7	11.04	5.52	0.92	0.00	0.92	0.46	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	7.63	2.51	1.25	0.21	0.63	0.42	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	11.46	3.02	0.75	0.15	0.00	0.60	0.45	0.30
Prostate Epithelial Cells, donor2	11331-117E8	22.07	4.47	0.81	1.08	0.54	0.95	0.27	0.00
Prostate Epithelial Cells, donor3	11404-118D9	9.80	1.71	1.10	0.06	0.00	0.37	0.24	0.12
Prostate Stromal Cells, donor1	11254-116F3	12.53	2.96	0.34	0.57	0.57	0.11	0.46	0.00
Prostate Stromal Cells, donor2	11332-117E9	6.99	2.51	1.08	0.54	0.18	0.54	0.36	0.18
Prostate Stromal Cells, donor3	11405-118E1	12.83	3.55	1.25	0.52	0.31	0.63	0.42	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	0.36	0.00	0.36	0.36	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	16.01	3.47	0.28	0.35	0.21	0.00	0.21	0.07
Renal Epithelial Cells, donor1	11517-119H5	10.14	4.06	0.00	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	6.40	0.71	0.00	0.71	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	23.61	4.34	0.74	0.74	1.27	0.00	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.30	2.04	0.00	0.68	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	10.65	3.50	1.35	1.08	0.54	0.13	0.13	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.97	7.77	2.00	2.00	1.33	0.44	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.31	2.66	0.00	0.67	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.92	2.20	0.66	0.22	0.44	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	10.66	0.63	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	2.22	0.55	0.00	0.83	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	7.78	1.34	0.81	0.54	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	6.75	1.69	1.27	0.00	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	9.84	1.54	0.58	0.00	0.58	0.00	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	4.15	1.30	0.26	0.78	1.04	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	8.24	1.14	0.85	0.00	0.57	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	2.06	0.00	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	2.51	0.50	0.50	0.50	0.25	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	44.50	10.96	4.81	2.27	2.54	2.14	0.67	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	17.87	2.68	0.89	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	12.11	3.85	0.55	0.00	0.00	0.55	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.14	4.64	0.00	0.58	0.00	1.16	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.72	6.11	1.56	0.52	0.00	0.39	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	15.89	8.04	1.09	0.50	0.40	0.10	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.29	8.70	1.00	0.67	0.22	0.11	0.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.98	7.69	1.24	0.37	0.12	0.12	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	17.37	6.99	1.05	0.12	0.58	0.23	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.49	8.09	0.92	0.46	0.00	0.23	0.46	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	15.47	8.76	0.82	0.68	0.41	0.00	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.91	8.62	1.06	0.30	0.15	0.61	1.06	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.04	10.57	2.51	0.00	0.54	0.00	0.54	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	15.64	7.17	1.43	0.14	0.00	0.14	1.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.84	6.12	1.40	0.00	0.54	0.11	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.69	5.97	1.11	0.89	0.22	0.66	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.63	8.99	0.96	0.38	0.19	0.38	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	16.96	7.92	1.49	0.75	0.47	0.28	0.28	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	24.99	13.34	2.63	0.56	0.38	0.38	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	20.04	8.49	1.59	1.06	0.66	0.00	0.27	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	20.05	8.57	1.36	0.68	0.58	0.19	0.58	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	16.61	5.92	0.76	0.76	0.76	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	20.29	8.65	1.39	0.53	0.53	0.00	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	15.98	10.65	1.12	1.12	0.00	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	21.70	9.23	1.54	0.68	0.68	0.17	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.24	9.30	0.91	0.91	0.36	0.18	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.47	6.62	1.35	0.25	0.12	0.12	0.49	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.60	9.54	1.34	0.94	0.81	0.27	1.21	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.86	8.26	1.65	1.65	0.24	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	15.87	6.15	0.99	0.60	0.20	0.00	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	23.38	7.95	1.64	0.70	0.70	0.23	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.00	6.43	1.24	1.24	0.83	0.21	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	15.71	7.96	1.11	0.66	0.00	0.44	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	17.76	8.15	1.46	0.84	0.00	0.00	0.84	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	19.78	6.19	1.48	1.21	0.67	0.13	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.27	10.56	2.38	1.02	0.51	0.17	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.56	6.94	1.35	1.54	0.96	0.39	0.58	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	22.01	8.25	1.72	1.20	0.17	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	21.12	9.60	1.92	0.96	0.27	0.00	0.69	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	23.80	7.88	0.16	0.33	0.82	0.16	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.62	7.33	1.02	0.34	0.17	0.17	1.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	14.35	5.33	2.07	0.89	0.30	0.30	0.89	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	22.12	9.86	1.33	0.53	0.27	0.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.87	5.81	0.97	0.14	0.28	0.14	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	15.95	5.71	1.67	0.48	0.00	0.00	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	28.62	10.48	3.02	0.81	0.60	0.00	0.81	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	15.35	3.20	1.04	0.94	0.38	0.38	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.42	7.69	2.10	0.70	0.35	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	17.23	8.76	0.91	0.30	0.30	0.30	0.30	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	17.26	6.49	1.22	0.73	0.00	0.49	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.18	20.38	3.64	2.04	0.73	0.73	2.18	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	17.64	15.21	2.43	0.61	0.00	0.00	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.07	8.14	2.11	0.60	0.30	0.90	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.07	11.08	3.62	0.45	0.23	0.00	0.90	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.65	11.38	2.40	0.30	0.60	0.30	1.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.06	8.74	2.36	0.35	0.24	1.65	0.59	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	30.10	12.17	3.63	0.85	0.64	2.56	1.07	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	31.25	13.82	1.80	0.00	0.00	0.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	4.14	2.26	0.19	0.19	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	3.40	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.95	1.97	1.10	0.66	0.22	0.00	0.66	0.00
Sebocyte, donor1	11220-116B5	20.82	3.29	0.55	0.55	0.55	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	7.35	1.38	0.46	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	4.33	1.24	0.41	0.21	0.21	0.00	0.41	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	1.66	3.31	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	14.12	5.65	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	15.66	4.40	0.70	0.44	0.70	0.44	0.35	0.26
Skeletal Muscle Cells, donor2	11358-117H8	9.40	2.89	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	14.21	4.18	1.67	0.00	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	5.18	3.14	0.94	0.16	0.00	0.00	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	6.84	2.53	0.30	0.30	0.59	0.00	0.30	0.15
Skeletal Muscle Cells, donor6	11459-119B1	7.08	2.00	0.92	0.31	0.15	0.15	0.31	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.65	3.78	1.26	0.50	0.38	0.25	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	11.99	2.71	0.71	0.29	0.29	0.14	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	11.51	3.67	0.79	0.40	0.50	0.20	0.50	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.01	4.89	1.60	0.34	0.25	0.42	0.51	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	10.13	3.62	0.72	0.72	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.67	3.44	1.24	0.41	0.41	0.14	0.28	0.41
Skin - palm, donor1	10286-104F7	21.49	10.74	5.37	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	10.81	5.62	0.86	0.29	0.29	0.72	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	36.81	12.27	5.73	3.27	1.64	1.64	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.96	2.34	0.65	0.65	0.52	0.65	0.39	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	17.51	1.95	0.97	0.14	0.42	0.70	0.28	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	18.57	2.53	1.27	0.70	0.70	0.28	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	54.34	8.67	3.81	1.90	0.85	0.21	0.21	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	16.86	2.10	1.20	0.22	0.15	0.00	0.15	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	12.03	1.54	0.93	0.62	0.00	0.00	0.62	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	24.46	7.78	2.89	1.11	1.11	0.44	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	4.11	0.00	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.60	3.54	1.55	1.10	0.44	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.33	1.58	0.00	0.00	0.39	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	8.50	3.86	0.77	2.32	0.77	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	22.02	3.00	2.00	0.00	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	9.98	1.20	0.40	0.93	0.40	0.13	0.00	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.76	2.22	0.66	0.66	0.22	0.22	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	12.03	3.33	1.02	1.66	0.77	0.13	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	12.05	3.26	0.98	0.33	0.33	0.00	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	14.77	5.91	1.18	0.59	0.30	0.00	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.81	5.69	1.00	0.43	0.28	0.00	0.57	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.95	0.81	0.00	0.00	0.00	0.00	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.27	5.48	1.22	2.44	0.30	0.30	0.61	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	4.04	2.27	0.51	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	0.00	12.24	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.95	0.48	0.48	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	15.19	4.87	0.29	0.59	0.44	0.00	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.99	3.87	0.65	0.22	0.65	0.43	0.65	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	14.90	2.83	1.15	0.52	0.73	0.00	0.52	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.95	2.01	0.31	0.46	0.15	0.00	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	2.16	1.08	1.08	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.47	1.49	0.60	0.00	0.60	0.60	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.78	1.02	0.34	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	17.67	4.55	1.26	0.39	0.31	0.00	0.31	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.98	5.84	1.81	0.81	0.60	1.11	0.70	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	6.37	5.01	1.14	0.46	0.46	0.46	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	2.42	1.81	0.00	0.60	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	8.74	1.59	0.00	0.53	0.26	0.53	0.26	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	13.98	3.06	0.93	0.67	0.27	0.40	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.40	3.51	0.38	0.88	1.38	0.25	0.63	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.60	2.28	1.01	0.25	0.51	0.51	1.01	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	16.89	3.77	0.75	0.30	0.30	0.15	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	2.25	5.25	0.00	0.75	0.00	0.00	0.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	2.58	3.88	1.29	2.58	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	20.00	4.65	0.93	1.40	0.93	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	1.51	0.50	2.02	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.89	3.76	0.63	0.63	0.63	0.00	0.63	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	1.77	0.00	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	10.33	3.42	0.75	0.50	0.58	0.33	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	2.80	0.47	0.00	0.00	0.00	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.06	1.30	0.86	0.72	0.00	0.00	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	7.90	1.53	0.76	1.02	0.51	0.00	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.02	1.88	0.75	0.00	0.56	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	11.88	3.35	0.98	0.98	0.00	0.14	0.42	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	15.84	2.35	0.67	0.50	0.17	0.00	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.48	0.48	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.10	0.98	0.24	0.24	0.24	0.00	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.92	4.86	0.44	1.99	0.22	1.10	0.44	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	7.61	0.88	0.59	0.29	0.88	0.00	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	14.58	5.64	0.39	0.39	0.00	0.00	0.97	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	11.37	3.70	0.53	1.06	0.26	0.26	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.07	1.12	0.37	0.00	0.37	1.12	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.01	3.59	1.08	0.36	0.36	1.08	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	11.07	4.83	0.00	0.57	1.42	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.27	1.97	0.00	0.00	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.63	2.03	0.25	0.76	0.00	0.51	0.00	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	8.79	2.40	1.60	0.40	0.00	0.80	0.80	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	4.60	0.42	0.84	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	14.21	4.13	0.46	0.46	0.46	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	21.04	4.71	1.85	1.18	1.18	0.17	0.00	0.17
Synoviocyte, donor2	11368-117I9	8.05	4.02	1.51	0.17	0.50	0.00	0.17	0.17
Synoviocyte, donor3	11440-118H9	6.26	6.93	2.23	0.00	0.00	0.67	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	4.65	1.43	1.07	0.00	0.36	0.00	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	3.96	0.00	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	5.56	0.93	0.93	0.69	0.23	0.00	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	8.96	0.93	0.07	0.72	0.43	0.29	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	8.89	0.39	0.77	0.00	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	0.00	0.57	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.01	9.23	3.94	4.06	2.83	1.35	0.12	0.00
Urethra, donor2	10319-105A4	39.57	7.19	0.00	7.19	0.00	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	6.64	1.33	0.53	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.21	0.40	0.00	0.80	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.42	0.92	0.23	0.46	0.46	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	41.46	2.90	0.89	2.67	1.34	0.00	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	3.56	2.67	0.00	0.00	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	2.86	4.29	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	2.74	2.05	0.00	0.00	0.00	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	2.41	7.23	0.34	0.69	0.00	0.00	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	1.16	3.49	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	2.08	6.25	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	0.00	8.26	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	1.83	7.30	0.00	0.00	0.00	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	4.93	1.23	1.23	0.00	0.12	0.12	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	15.84	20.24	0.88	0.00	0.88	0.88	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.89	2.79	1.12	0.56	0.00	0.00	0.28	0.56
achilles tendon, donor2	10292-104G4	28.93	2.07	4.13	6.20	4.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.20	1.78	1.27	0.00	0.00	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.13	0.93	0.00	0.23	0.23	0.23	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	9.02	4.99	0.47	0.12	0.12	0.24	0.36	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	3.81	2.72	0.27	0.00	0.00	0.00	0.54	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	7.19	2.75	0.63	0.42	0.00	0.21	1.06	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	4.63	3.27	0.54	0.27	0.27	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	3.08	3.08	0.44	0.00	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.41	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	7.38	3.11	0.39	0.78	0.00	0.00	0.39	1.55
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	0.37	0.00	0.18	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	4.42	3.95	0.93	0.00	0.70	0.00	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	5.18	3.37	1.29	0.00	0.00	0.00	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	3.51	4.38	0.58	0.00	0.00	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	0.93	1.39	0.00	0.00	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3.29	0.41	0.41	0.41	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	3.07	2.76	0.92	0.00	0.00	0.31	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	5.12	4.27	0.00	0.43	0.43	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	6.07	5.16	1.21	0.00	0.30	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	8.18	4.81	0.72	0.48	0.00	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	2.23	0.67	0.22	0.00	0.00	0.00	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.34	5.67	0.67	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	20.44	5.57	0.00	0.00	5.57	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	3.77	4.90	0.75	0.00	0.00	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	1.87	9.37	0.00	1.87	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	9.18	1.18	0.47	0.24	0.24	0.00	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	41.26	7.60	3.88	2.64	1.71	2.17	0.62	0.16
adipose, donor1	10184-103D4	5.28	0.00	0.00	0.59	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	8.52	4.46	1.62	0.41	0.00	0.00	3.24	1.22
adipose, donor3	10186-103D6	8.44	3.00	2.18	0.27	0.00	1.09	0.00	0.27
adipose, donor4	10187-103D7	19.07	10.40	11.27	9.53	0.00	0.00	0.00	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.16	5.52	1.58	0.63	0.00	0.00	1.74	1.42
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	7.20	1.87	0.13	0.27	0.27	0.27	0.27	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	15.36	3.22	1.07	0.00	1.07	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	39.41	7.19	5.33	1.16	1.62	0.70	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	22.31	5.75	3.38	1.35	0.34	1.69	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	15.91	4.71	2.65	0.59	1.18	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	16.60	17.79	5.93	3.56	2.37	2.37	5.93	1.19
amygdala, adult, donor10252	10151-102I7	33.05	17.24	3.65	2.84	2.03	1.42	2.03	2.84
amygdala, newborn, donor10223	10360-105E9	21.63	16.14	1.29	2.26	2.58	1.61	0.97	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	40.24	2.55	1.91	0.51	0.38	0.64	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	4.41	2.65	1.32	0.00	0.00	0.22	0.22	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	5.01	13.70	1.67	1.34	0.00	1.34	1.34	3.67
aorta, adult, pool1	10052-101G7	29.22	9.81	3.53	1.96	2.16	0.78	0.20	0.20
appendix, adult	10189-103D9	27.94	10.48	2.33	3.10	1.16	1.16	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	8.60	2.75	0.00	0.00	0.34	0.00	0.00	0.00
artery, adult	10190-103E1	23.10	5.43	1.36	1.36	2.72	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	13.04	6.37	1.88	0.72	0.00	0.29	0.58	0.00
b cell line:RPMI1788	10427-106D4	7.58	5.35	0.74	0.45	0.15	0.15	0.30	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	20.25	5.83	1.94	2.22	1.39	0.00	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.82	2.48	0.50	0.40	0.20	0.00	0.20	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	5.19	2.18	0.00	0.33	0.17	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	2.24	0.56	0.00	0.00	0.00	0.00	1.12	0.00
bladder, adult, pool1	10011-101C2	44.43	7.93	3.26	2.61	1.20	1.09	0.65	0.22
blood, adult, pool1	10053-101G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	4.28	1.71	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	23.62	4.05	2.70	0.67	1.35	1.35	0.00	0.00
brain, adult, donor1	10084-102B3	14.35	16.40	3.08	2.05	1.03	2.05	4.10	1.03
brain, adult, pool1	10012-101C3	25.61	20.49	4.12	3.34	1.67	4.01	3.23	0.56
brain, fetal, pool1	10085-102B4	64.11	21.37	5.34	5.34	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	29.73	9.91	2.64	1.65	1.65	0.33	0.33	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	48.31	8.86	5.24	1.62	0.87	0.25	0.87	0.12
breast, adult, donor1	10080-102A8	29.04	2.53	4.42	0.00	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	3.94	2.67	0.89	0.38	0.13	0.13	0.38	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	12.68	2.47	0.62	0.00	0.00	0.00	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	5.76	1.38	0.46	0.46	0.46	0.92	0.46	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	10.65	2.18	2.91	0.24	0.00	0.24	0.00	0.48
carcinoid cell line:NCI-H1770	10703-109H1	10.81	0.47	0.00	0.94	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	17.61	1.97	1.09	0.33	0.33	0.00	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	10.14	1.27	1.58	0.32	0.00	1.27	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	14.37	5.06	1.86	0.80	0.27	0.80	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	18.42	29.93	3.45	3.45	3.45	1.15	6.91	3.45
caudate nucleus, adult, donor10252	10164-103B2	18.91	30.62	1.84	1.67	1.17	1.67	3.01	2.68
caudate nucleus, adult, donor10258	10379-105H1	14.52	32.86	1.53	0.00	0.76	5.35	9.93	4.58
caudate nucleus, newborn, donor10223	10354-105E3	13.92	30.03	0.37	1.10	0.73	2.93	2.93	0.73
cerebellum - adult, donor10196	10173-103C2	32.05	20.39	2.91	5.83	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	46.97	18.58	8.54	3.42	0.21	0.85	1.28	0.43
cerebellum, adult, pool1	10083-102B2	14.83	5.17	2.76	1.38	1.72	1.03	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	31.55	36.53	1.66	0.83	0.83	0.00	1.66	0.83
cerebral meninges, adult	10188-103D8	30.76	23.20	3.78	5.80	1.51	3.53	4.03	5.04
cerebrospinal fluid, donor2	10294-104G6	6.58	2.92	1.46	0.73	0.73	0.73	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	4.03	2.59	0.14	0.14	0.00	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	11.60	2.49	1.16	0.17	0.17	0.00	0.17	0.00
cervix, adult, pool1	10013-101C4	60.68	15.22	4.20	3.04	2.62	3.04	1.05	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	11.84	3.07	0.70	0.00	0.14	0.28	0.56	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	18.29	3.92	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	6.71	9.32	0.75	0.37	0.12	0.50	0.37	0.12
choriocarcinoma cell line:SCH	10785-110H2	1.97	3.20	0.25	0.00	0.00	0.25	0.12	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	7.83	6.40	3.32	0.00	0.00	0.00	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	30.20	5.70	6.27	0.57	0.28	0.28	1.14	0.57
chorionic membrane cells, donor2	12239-129G7	36.69	4.57	2.19	1.89	0.60	1.39	0.40	0.10
chorionic membrane cells, donor3	12240-129G8	37.91	8.24	10.99	1.10	0.00	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	2.69	4.23	0.77	0.19	0.19	0.38	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	2.32	2.75	0.63	0.00	0.00	0.63	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.85	2.57	0.51	0.00	0.00	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	3.39	0.97	0.24	0.00	0.00	0.00	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	3.46	1.43	0.61	0.00	0.20	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	2.06	0.29	0.59	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	3.39	5.73	0.26	0.00	0.52	0.00	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	7.31	2.51	1.83	0.00	0.23	0.69	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	6.59	2.60	0.35	0.17	0.52	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	14.09	1.83	0.92	0.37	0.00	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	14.82	3.42	0.76	0.00	0.76	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	11.90	2.38	4.76	1.19	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	41.60	6.93	3.64	1.76	1.88	2.23	0.47	0.12
colon, fetal, donor1	10070-101I7	24.72	5.56	1.85	2.47	1.85	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	13.75	22.92	0.00	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	11.47	5.52	1.70	0.42	0.42	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	4.68	2.57	1.36	0.00	0.15	0.15	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	3.95	2.26	1.27	0.28	0.00	0.00	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	26.65	10.39	2.10	1.99	1.99	2.54	0.66	0.44
cruciate ligament, donor2	10295-104G7	21.88	10.54	0.81	3.24	4.05	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	16.05	11.24	1.61	0.00	0.00	1.61	0.80	0.00
diencephalon, adult	10193-103E4	15.60	10.08	0.96	1.68	0.72	2.64	2.16	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.35	3.67	0.69	0.00	0.00	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	6.41	2.31	0.77	0.00	0.00	0.00	0.00	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	3.37	3.13	0.96	0.24	0.24	0.24	0.72	0.24
ductus deferens, adult	10196-103E7	20.93	3.99	1.99	2.49	0.50	1.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	7.20	4.32	4.32	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	29.43	13.98	5.15	2.94	2.21	1.47	0.00	0.00
dura mater, adult, donor1	10041-101F5	38.40	12.64	3.30	4.96	2.15	0.99	1.32	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	15.77	3.11	0.44	0.67	0.67	0.67	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.61	4.16	0.72	0.14	0.43	0.29	0.29	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	6.78	2.47	2.47	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	7.87	3.33	0.61	0.30	0.00	0.00	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.29	7.41	0.93	0.62	0.00	0.00	0.62	0.31
embryonic pancreas cell line:2C6	10603-108E9	10.51	5.25	1.31	0.00	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	16.09	5.36	1.01	0.00	0.34	0.34	0.67	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	22.65	3.62	2.90	0.72	0.54	0.54	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	5.15	4.99	1.13	0.16	0.00	0.00	0.64	0.16
epidermoid carcinoma cell line:A431	10426-106D3	9.23	2.11	0.56	0.44	0.11	0.11	0.44	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.22	5.06	1.10	0.33	0.22	0.11	0.44	0.00
epididymis, adult	10197-103E8	31.40	7.74	4.19	0.63	1.05	2.30	1.26	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.93	4.79	1.60	1.77	1.77	0.71	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	5.51	2.36	0.79	0.00	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	3.93	0.39	0.13	0.26	0.00	0.13	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	4.92	0.39	0.20	0.20	0.30	0.10	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	4.71	1.01	0.22	0.22	0.00	0.11	0.00	0.00
esophagus, adult, pool1	10015-101C6	33.02	6.48	3.61	2.23	0.85	0.85	0.32	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	8.27	21.16	1.75	0.25	0.50	0.38	3.63	1.75
eye - muscle inferior rectus, donor1	10272-104E2	33.80	12.07	2.41	4.83	2.41	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	18.94	4.21	0.00	6.31	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	4.46	0.00	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	13.76	5.73	1.15	3.44	4.59	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	14.57	1.46	7.29	2.91	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	24.66	8.14	2.54	3.05	0.76	0.76	1.53	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	4.49	1.28	0.64	0.26	0.00	0.13	0.51	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	9.02	2.61	1.19	0.00	0.71	0.47	0.24	0.71
frontal lobe, adult, pool1	10040-101F4	35.65	30.31	5.72	4.13	1.50	3.47	2.81	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.61	10.21	1.50	0.90	0.00	0.00	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	20.94	3.20	0.82	0.46	0.55	0.18	0.27	0.00
gall bladder, adult	10198-103E9	33.08	8.69	2.17	2.41	1.93	1.93	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	1.61	6.44	0.54	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	1.49	12.33	0.75	0.00	0.37	0.00	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.53	3.59	1.90	0.42	0.21	0.21	0.63	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	8.51	3.09	1.35	0.58	0.58	0.00	0.00	0.39
gastric cancer cell line:AZ521	10549-107H9	14.43	3.12	0.98	0.49	0.98	0.00	0.66	0.16
gastric cancer cell line:GSS	10560-108A2	3.66	4.58	0.92	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	7.31	8.68	0.69	0.23	0.23	0.46	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	1.38	0.69	0.11	0.00	0.00	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	31.77	6.86	1.12	1.12	0.84	0.00	0.56	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	10.48	2.24	1.50	0.25	0.25	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.67	2.43	1.37	0.95	1.37	0.11	0.32	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.23	2.11	2.39	1.12	0.98	0.28	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	13.69	1.10	0.88	0.55	0.55	0.00	0.11	0.11
glioma cell line:GI-1	10413-106B8	17.57	1.76	0.29	0.29	0.59	0.88	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	6.56	4.37	0.73	0.00	2.92	0.00	2.19	1.46
globus pallidus, adult, donor10252	10161-103A8	26.61	10.01	1.71	1.95	1.95	0.00	1.22	0.24
globus pallidus, adult, donor10258	10367-105F7	6.85	13.69	0.00	1.37	0.00	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	23.45	11.72	1.07	1.07	2.13	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	12.24	4.89	0.00	0.00	0.00	2.45	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.80	5.76	0.64	0.00	0.00	0.00	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	7.80	3.21	0.00	0.46	0.00	0.46	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.40	5.03	1.37	0.00	0.00	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	3.22	4.51	0.00	1.93	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	2.87	5.75	0.00	0.00	0.00	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	7.54	4.12	2.06	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	12.14	18.76	3.31	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.00	1.15	0.00	0.29	0.00	0.00	0.29	0.29
heart - mitral valve, adult	10205-103F7	40.66	10.46	2.99	2.39	2.99	0.90	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	39.48	10.20	3.14	3.14	2.09	1.05	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	70.77	22.48	8.33	4.16	2.50	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	15.10	4.90	1.84	1.63	0.82	0.00	0.41	0.00
heart, adult, diseased, donor1	10051-101G6	22.99	6.39	2.55	3.83	1.28	2.13	0.00	0.43
heart, adult, pool1	10016-101C7	60.25	7.59	3.22	5.75	1.38	0.46	0.46	0.00
heart, fetal, pool1	10046-101G1	73.52	13.66	5.85	4.62	2.67	0.41	0.82	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	23.45	5.55	1.23	0.93	1.23	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	5.95	5.95	0.00	0.00	2.38	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	8.18	3.87	0.55	0.44	0.66	0.00	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	9.22	4.01	0.61	0.61	0.24	0.24	0.36	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	10.51	4.45	0.81	0.20	0.20	0.20	0.40	0.10
hepatoma cell line:Li-7	10484-107A7	10.34	1.56	0.11	0.33	0.33	0.56	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	3.52	2.11	0.10	0.10	0.00	0.10	0.40	0.00
hippocampus - adult, donor10196	10169-103B7	9.46	22.71	2.84	2.84	0.00	3.79	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	33.68	16.74	5.71	3.88	1.63	1.22	2.25	1.63
hippocampus, adult, donor10258	10374-105G5	15.44	31.37	2.49	3.49	1.49	1.99	3.49	0.00
hippocampus, newborn, donor10223	10363-105F3	15.16	40.53	1.76	0.35	2.82	3.88	3.52	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	7.32	4.27	0.61	0.00	0.00	0.61	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.30	9.23	0.59	0.20	0.00	0.39	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.33	8.63	0.25	0.00	0.00	0.25	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.38	1.69	0.00	0.00	0.00	0.00	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	14.20	2.32	1.55	0.00	0.00	0.52	0.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.69	1.14	0.00	0.00	0.00	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	15.47	5.84	1.46	0.00	0.29	0.58	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.10	5.82	0.65	0.43	0.86	1.29	1.08	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	12.10	7.92	2.09	0.00	0.00	0.42	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	13.02	4.03	0.95	0.24	0.24	0.47	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	14.14	3.54	0.64	0.32	0.16	0.80	0.32	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	12.79	8.08	0.67	0.00	1.35	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.85	4.23	0.63	0.31	0.00	0.16	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	2.95	1.97	0.00	0.00	0.49	0.49	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	2.62	0.87	0.00	0.00	0.00	0.87	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	10.69	2.29	0.57	0.00	0.00	0.76	0.19	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.47	1.31	0.44	0.44	0.00	1.31	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5.00	2.00	0.50	0.00	0.50	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	10.55	3.77	0.57	0.57	0.19	0.19	1.70	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.73	4.55	0.91	0.00	0.45	0.91	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.14	4.70	1.25	0.00	0.00	0.63	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	9.31	5.55	1.31	0.16	0.16	0.49	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.87	5.81	1.74	0.00	0.29	0.58	0.29	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	9.27	6.88	0.60	0.00	0.00	0.90	0.60	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	6.84	6.65	0.37	0.55	0.00	0.37	0.74	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.85	4.85	0.00	0.29	0.00	0.00	0.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	8.98	2.86	1.22	0.00	0.00	0.82	0.00	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	5.99	1.41	1.76	0.35	0.00	0.70	0.35	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.07	2.53	0.00	0.00	0.32	0.00	0.32	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.96	1.82	0.30	0.30	0.00	0.30	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.79	5.17	1.03	0.52	0.00	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.96	1.33	0.66	0.66	0.00	0.00	1.33	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	11.54	4.87	0.77	0.00	0.26	0.00	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	12.02	4.09	1.79	0.26	0.26	0.26	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.12	8.33	0.76	0.00	1.51	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.75	5.04	0.00	0.34	1.01	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	6.04	4.35	0.97	0.72	0.00	0.24	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	5.79	7.13	0.89	0.00	0.00	1.78	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	6.83	3.90	0.49	0.00	0.49	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.61	2.44	0.31	0.00	0.00	0.61	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	3.25	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.93	0.66	0.33	0.33	0.33	0.99	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	16.42	6.02	1.64	0.55	0.00	1.09	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	13.03	3.62	0.72	0.00	0.00	0.00	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.46	4.98	0.36	0.00	0.36	0.36	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	9.55	3.58	1.19	0.00	1.19	2.39	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	18.28	6.23	0.54	0.27	0.27	1.22	0.54	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.08	2.42	0.54	0.00	0.27	0.54	0.27	0.54
immature langerhans cells, donor1	11904-125F5	5.81	5.33	1.21	1.21	0.00	0.00	0.48	0.00
immature langerhans cells, donor2	11905-125F6	12.67	7.13	0.79	0.00	0.79	0.79	0.79	0.00
insula, adult, pool1	10039-101F3	44.38	38.61	5.49	4.45	3.22	4.26	2.93	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	11.06	1.30	0.98	0.65	0.65	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	24.83	5.31	2.50	2.50	1.70	0.80	0.10	0.20
kidney, fetal, pool1	10045-101F9	46.61	10.89	2.83	2.05	1.63	0.57	0.57	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.34	8.24	1.42	1.28	0.14	0.43	0.43	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	4.42	0.14	0.55	0.28	0.00	0.14	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	8.81	3.85	0.55	0.55	0.00	0.18	0.18	0.55
left atrium, adult, donor1	10079-102A7	12.53	5.45	0.54	1.09	0.54	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	11.63	7.58	1.52	1.52	1.01	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	14.50	4.10	1.64	0.00	0.82	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	3.95	2.87	0.72	0.36	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	7.07	3.26	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	5.34	2.19	0.24	0.73	0.73	0.00	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	27.18	4.18	2.09	1.05	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	9.09	5.08	0.71	0.24	0.12	0.12	0.47	0.12
liposarcoma cell line:KMLS-1	10782-110G8	23.28	3.59	1.87	1.25	0.78	0.31	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	13.89	0.97	1.10	0.85	0.73	0.00	0.12	0.24
liver, adult, pool1	10018-101C9	26.42	2.76	1.62	0.97	0.81	1.30	0.16	0.16
liver, fetal, pool1	10086-102B5	4.70	3.76	0.94	0.94	0.00	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	22.31	11.23	2.62	2.92	2.77	0.73	1.17	0.73
locus coeruleus, adult, donor10252	10165-103B3	31.37	13.66	3.51	3.51	1.48	0.55	0.55	0.37
locus coeruleus, adult, donor10258	10375-105G6	15.80	12.70	1.69	0.56	1.69	2.54	1.13	1.69
locus coeruleus, newborn, donor10223	10362-105F2	26.50	7.15	1.68	1.26	0.84	3.36	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	10.52	1.38	0.97	0.42	0.55	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	13.79	0.00	0.69	0.69	1.38	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	7.38	1.45	0.92	0.00	0.00	0.13	0.26	0.13
lung, adult, pool1	10019-101D1	91.78	18.78	3.31	5.08	4.25	4.02	0.83	0.71
lung, fetal, donor1	10068-101I5	83.34	37.39	7.99	11.42	3.14	3.42	0.86	0.29
lung, right lower lobe, adult, donor1	10075-102A3	39.41	12.37	5.04	2.29	5.96	6.42	0.46	0.46
lymph node, adult, donor1	10077-102A5	5.21	6.63	0.95	0.00	0.00	1.42	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	3.07	1.32	0.88	0.22	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	10.26	4.68	1.51	0.45	0.30	0.15	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	4.25	14.44	1.70	0.85	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	51.06	4.00	2.22	3.55	2.22	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	54.99	6.02	3.11	2.28	3.74	1.04	0.62	0.21
mature adipocyte, donor3	12233-129G1	42.20	4.74	3.56	3.08	3.08	1.90	0.24	0.47
mature adipocyte, donor4	12234-129G2	37.64	4.47	3.16	3.42	2.63	1.32	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	20.49	4.05	2.14	0.95	0.48	0.48	0.00	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	28.20	2.26	4.51	1.13	0.00	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	29.61	19.13	5.15	3.13	1.10	1.47	1.84	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	16.52	2.86	2.54	0.95	2.54	4.45	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	20.04	15.35	2.13	6.40	0.85	4.69	0.43	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	14.01	20.76	3.04	3.38	1.35	3.38	3.38	1.52
medial temporal gyrus, adult, donor10252	10156-103A3	25.04	23.13	7.22	5.31	0.64	1.06	2.55	1.49
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	1.93	30.82	0.00	5.78	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	25.48	28.71	3.59	2.15	4.31	3.23	3.23	1.44
medulla oblongata - adult, donor10196	10174-103C3	14.28	7.79	1.30	2.60	0.00	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	34.37	10.06	3.41	2.48	1.70	0.93	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	36.24	13.88	2.69	3.10	2.29	1.80	0.57	0.24
medulla oblongata, newborn, donor10223	10361-105F1	23.61	11.11	1.04	0.69	0.69	0.00	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	30.33	20.15	3.76	0.66	0.44	0.89	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	6.85	1.83	0.37	0.00	0.00	0.00	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	9.92	2.87	0.86	0.29	0.00	0.29	0.14	0.29
melanoma cell line:G-361	10465-106H6	16.02	4.89	0.00	0.00	0.54	1.36	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	11.76	1.81	0.72	0.36	0.36	0.00	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.91	8.81	2.64	0.00	0.88	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	23.33	7.52	1.81	0.26	0.26	0.00	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	13.04	2.15	1.53	0.46	0.46	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.00	2.73	1.45	0.73	0.36	0.00	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	4.14	3.31	0.83	0.41	0.00	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	3.93	2.11	0.84	0.00	0.00	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	4.81	4.04	0.39	0.77	0.00	0.58	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	6.25	0.00	0.00	0.69	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	5.49	2.06	0.00	0.00	0.00	0.34	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	5.75	2.53	0.81	0.35	0.00	0.23	0.46	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.86	2.92	0.40	0.80	0.27	0.27	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	10.13	2.16	1.35	0.54	0.81	0.41	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.36	4.98	1.00	0.57	0.14	0.00	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	3.95	0.66	0.99	0.66	0.33	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.54	3.87	1.38	1.11	0.42	0.42	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.31	3.49	1.75	1.05	1.40	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	14.29	3.06	0.20	0.61	0.61	0.41	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	9.35	3.95	0.72	1.08	0.36	0.00	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.24	3.31	0.93	0.21	0.62	0.21	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.52	6.61	0.91	0.46	0.46	0.23	0.91	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	11.75	4.62	1.68	1.68	0.84	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.91	1.64	0.45	0.60	0.30	0.15	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	13.30	1.58	1.05	0.53	0.53	0.00	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.62	5.89	2.21	0.74	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	16.02	6.01	1.43	0.57	0.86	0.57	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	13.47	2.53	0.84	0.84	1.68	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.33	3.20	0.46	0.00	1.83	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.32	4.60	1.02	0.77	1.28	0.77	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.35	4.19	1.05	0.52	0.52	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	19.10	5.55	0.92	0.62	1.23	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.47	3.29	1.88	1.18	1.18	0.47	0.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	13.88	2.71	1.02	0.00	1.02	0.00	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	15.33	4.72	0.79	0.79	1.57	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	8.80	6.02	0.93	0.00	1.85	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.59	4.61	2.02	1.15	0.58	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	15.84	3.35	1.56	0.22	0.67	0.00	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.42	4.33	2.16	1.20	0.72	0.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	2.93	2.20	0.00	0.00	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.73	2.69	0.67	0.34	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	15.15	3.28	0.82	1.64	0.00	0.41	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.03	3.44	0.00	0.86	1.29	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.02	3.25	0.97	0.65	0.97	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	1.45	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	8.00	3.20	2.13	0.53	0.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	8.18	4.09	0.82	0.00	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	12.05	5.05	0.39	0.39	0.00	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	4.20	0.00	0.00	0.00	0.00	4.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	6.95	0.99	1.99	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	8.89	1.19	0.59	0.00	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	3.66	3.66	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	8.87	1.90	1.90	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	10.69	1.72	1.38	0.00	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	10.75	0.00	0.00	0.00	2.15	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.30	1.22	0.41	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	1.59	0.79	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	3.54	3.54	0.00	0.59	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	4.36	2.81	0.00	0.00	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	1.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	7.70	0.00	2.57	0.00	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	4.82	0.69	1.38	0.00	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	2.97	1.48	1.48	0.00	0.49	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	3.36	2.24	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	6.36	3.82	0.64	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.42	0.00	0.40	0.00	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	0.00	1.27	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	1.82	0.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	1.65	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.54	1.79	0.60	0.60	0.20	0.00	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.87	1.95	0.32	0.32	0.00	0.65	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	3.06	4.07	0.00	1.02	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	36.36	5.42	2.32	0.77	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	12.99	3.54	0.71	0.24	0.00	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.63	8.57	1.62	0.46	0.93	0.46	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	5.03	2.36	0.51	0.21	0.21	0.10	0.10	0.00
mesothelioma cell line:Mero-25	10850-111F4	1.59	2.04	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	17.36	1.22	0.24	1.71	0.49	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	4.65	4.43	0.66	0.44	0.22	0.00	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	13.40	2.37	1.31	0.53	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	8.17	2.21	0.85	0.85	0.51	0.00	0.00	0.00
mesothelioma cell line:Mero-84	10855-111F9	12.64	4.80	1.01	1.77	1.01	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	6.00	2.90	1.04	0.21	0.21	0.00	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	8.28	3.31	0.83	1.16	0.50	0.17	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	5.07	0.54	0.18	0.36	0.18	0.00	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	8.37	1.37	0.51	0.34	0.34	0.00	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	12.98	2.80	1.02	0.51	0.25	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	3.26	1.30	0.00	0.33	0.00	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	5.69	1.90	0.00	0.81	0.54	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	10.56	3.07	0.58	0.77	0.96	0.00	0.38	0.19
migratory langerhans cells, donor2	11902-125F3	15.39	6.35	3.42	0.24	0.24	0.12	0.24	0.12
migratory langerhans cells, donor3	11903-125F4	11.67	3.95	1.44	1.08	0.00	0.18	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	6.86	3.26	0.00	0.65	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	2.54	2.76	0.00	0.00	0.00	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	6.68	1.38	0.92	0.92	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	1.90	3.04	0.76	0.19	0.19	0.00	0.57	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	13.67	3.88	0.55	0.92	0.18	0.00	0.18	0.18
myeloma cell line:PCM6	10474-106I6	6.13	2.97	0.40	0.59	0.00	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	18.26	7.10	2.03	0.51	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	10.14	0.67	0.22	0.11	0.33	0.00	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	7.43	0.81	0.37	0.15	0.07	0.15	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	17.11	0.55	4.97	3.31	0.00	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	59.13	8.74	1.15	1.38	0.46	0.69	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	27.50	13.10	2.43	0.94	1.50	0.56	0.37	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	13.71	2.53	1.48	0.42	0.00	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	32.43	8.76	1.12	0.75	0.37	0.56	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	10.20	11.39	0.95	0.47	0.24	0.47	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	7.92	9.82	1.43	0.79	0.63	0.95	0.79	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	7.85	2.62	0.60	0.00	0.20	0.20	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.81	6.36	1.91	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	14.37	6.92	2.40	0.53	0.80	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	61.56	5.58	4.90	1.52	1.18	0.51	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	23.21	2.40	0.00	0.80	0.80	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	11.86	5.77	1.92	1.92	0.00	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	36.26	4.99	1.84	2.89	2.63	0.26	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	34.12	31.40	4.97	4.12	2.25	3.66	3.94	0.66
occipital cortex - adult, donor10196	10172-103C1	22.66	20.60	4.12	2.06	0.00	0.00	10.30	0.00
occipital cortex, adult, donor10252	10163-103B1	28.45	15.57	6.71	6.71	0.54	1.88	3.22	1.34
occipital cortex, newborn, donor10223	10355-105E4	33.85	38.58	2.18	3.28	1.46	3.64	4.73	2.18
occipital lobe, adult, donor1	10076-102A4	17.84	12.60	5.77	2.36	0.52	6.30	4.99	5.77
occipital lobe, fetal, donor1	10073-102A1	62.65	18.02	6.44	3.00	0.43	4.29	1.72	2.15
occipital pole, adult, pool1	10036-101E9	26.88	20.18	4.97	3.23	1.73	2.76	2.60	0.39
olfactory region, adult	10195-103E6	24.26	24.07	5.35	4.01	1.15	2.87	4.01	0.96
optic nerve, donor1	10277-104E7	22.01	8.00	4.00	4.00	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	12.99	3.19	1.37	0.57	0.11	0.23	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	5.91	1.79	0.00	0.27	0.00	0.14	0.27	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	5.25	2.88	2.03	0.51	0.17	0.00	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	10.28	1.50	0.23	0.35	0.23	0.12	0.35	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	31.16	4.41	1.76	1.18	2.35	0.59	1.18	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	42.98	11.21	3.74	0.93	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	12.09	6.36	0.00	0.64	0.42	0.00	0.21	0.21
ovary, adult, pool1	10020-101D2	44.55	12.32	2.62	1.48	1.66	1.66	0.44	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	8.80	2.75	0.92	0.18	0.92	0.18	0.18	0.18
pancreas, adult, donor1	10049-101G4	7.53	2.82	0.00	1.88	0.00	0.00	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	4.47	4.75	0.84	0.00	0.00	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	4.43	1.87	0.68	0.17	0.00	0.51	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.31	5.80	2.48	1.32	2.32	0.66	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	31.67	28.37	6.13	5.13	1.83	2.84	3.29	0.64
parietal cortex, adult, donor10258	10373-105G4	18.35	18.35	3.67	5.14	0.73	2.20	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	13.17	11.29	1.88	2.82	0.00	0.94	3.76	0.00
parietal lobe, adult, donor10252	10157-103A4	21.95	19.67	3.14	4.85	2.00	2.28	0.86	0.86
parietal lobe, adult, pool1	10034-101E7	30.14	30.67	5.29	3.79	1.32	3.17	3.26	0.26
parietal lobe, fetal, donor1	10072-101I9	62.07	21.34	4.85	1.94	1.94	4.85	0.97	3.88
parietal lobe, newborn, donor10223	10356-105E5	20.94	25.80	4.49	2.99	1.12	1.50	2.24	0.75
parotid gland, adult	10199-103F1	17.27	1.85	1.23	1.85	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	37.06	6.98	4.30	3.22	2.15	3.76	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.44	13.39	0.19	0.00	0.19	0.37	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	19.81	3.64	2.62	1.46	0.58	0.44	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	43.86	11.61	1.94	3.87	1.94	0.65	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	94.75	29.02	7.70	6.51	1.18	1.18	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	35.12	8.15	2.51	4.39	1.25	1.25	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	38.45	9.11	1.01	3.04	0.00	1.01	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	56.81	14.07	2.08	3.13	1.56	2.08	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	12.77	5.11	2.55	0.00	0.00	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	39.99	13.98	6.77	1.61	0.97	0.86	0.43	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	6.75	3.05	0.53	0.13	0.26	0.13	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	30.35	4.51	2.33	1.71	2.65	0.00	0.31	0.00
pons, adult, pool1	10033-101E6	43.12	20.48	3.79	3.70	1.46	1.55	1.81	0.09
postcentral gyrus, adult, pool1	10032-101E5	26.85	19.79	4.97	3.23	1.13	2.01	3.66	0.52
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	6.27	0.00	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.47	1.89	0.87	0.15	0.29	0.15	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	15.06	3.63	0.54	0.36	0.36	0.18	0.00	0.18
prostate, adult, pool1	10022-101D4	45.89	8.80	2.09	1.72	2.00	1.27	0.54	0.63
putamen, adult, donor10196	10176-103C5	16.52	36.35	2.36	3.54	0.94	2.36	4.96	0.71
putamen, adult, donor10252	10152-102I8	19.61	21.57	1.96	0.00	0.00	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	2.19	17.48	1.09	0.00	0.00	0.00	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	11.36	26.82	2.17	1.93	1.69	2.66	4.11	1.69
putamen, newborn, donor10223	10365-105F5	15.74	9.75	2.25	0.75	0.75	3.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	10.18	2.62	0.29	0.29	0.29	0.00	0.58	0.29
rectum, fetal, donor1	10067-101I4	23.65	5.56	4.17	5.56	2.78	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	6.57	1.06	0.21	0.64	0.85	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	12.43	1.24	1.24	0.00	0.00	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	50.69	13.52	2.88	4.47	2.09	1.49	0.99	0.40
retinoblastoma cell line:Y79	10475-106I7	35.33	7.79	2.34	0.00	0.78	0.26	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	12.05	2.70	0.86	0.49	0.49	0.25	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	33.74	2.53	1.69	1.12	0.84	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	34.86	6.06	1.52	1.52	3.03	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	11.17	3.08	0.97	0.65	0.16	0.49	0.00	0.16
salivary acinar cells, donor2	11772-123I8	11.70	2.75	2.48	0.41	0.96	0.28	0.41	0.00
salivary acinar cells, donor3	11773-123I9	29.79	2.65	3.31	2.65	2.65	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	18.87	2.86	4.58	1.14	0.57	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	9.36	3.04	0.67	0.34	0.34	0.34	0.42	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	6.23	3.53	0.47	0.24	0.59	0.71	0.24	0.24
seminal vesicle, adult	10201-103F3	26.98	4.23	4.76	2.12	1.06	1.06	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	12.88	3.40	1.21	0.49	0.73	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.80	3.52	2.52	0.25	0.25	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	14.05	2.01	2.01	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.12	6.31	0.94	1.07	0.67	0.54	0.67	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	4.97	0.77	0.33	0.22	0.44	0.00	0.22	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	3.61	0.65	0.77	0.00	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	11.35	2.13	0.71	1.42	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	31.30	5.28	1.44	1.44	1.68	0.72	0.12	0.00
skeletal muscle, fetal, donor1	10066-101I3	8.04	3.02	1.01	1.01	1.01	2.01	0.00	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	6.79	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	18.31	8.84	2.52	1.26	1.26	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.01	5.67	3.00	0.33	1.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	30.89	14.18	0.63	0.95	0.63	0.63	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.60	4.63	4.05	0.96	0.58	0.00	0.77	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	18.96	2.97	1.32	0.49	0.16	0.33	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.75	12.87	0.97	0.32	0.00	0.32	0.64	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	18.96	2.62	2.83	1.09	0.44	0.44	0.00	0.00
small intestine, adult, pool1	10024-101D6	45.27	7.64	2.87	1.79	0.96	1.79	0.24	0.48
small intestine, fetal, donor1	10064-101I1	17.44	3.44	1.23	0.49	1.23	0.74	0.74	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	2.05	2.56	0.00	0.00	0.51	0.00	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	27.65	8.01	3.10	1.03	1.03	1.03	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	12.60	3.48	0.54	0.27	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	14.22	10.78	2.06	1.38	2.52	1.61	1.15	0.46
spinal cord, adult, donor10252	10159-103A6	20.50	6.70	1.97	1.18	0.79	0.39	1.18	0.39
spinal cord, adult, donor10258	10369-105F9	7.61	2.77	0.00	0.69	2.77	1.38	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	33.54	19.51	5.49	3.05	3.66	3.05	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	15.61	7.35	0.92	0.92	1.38	1.84	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.10	5.53	1.79	1.49	0.90	0.30	0.30	0.45
spleen, adult, pool1	10025-101D7	26.76	8.81	2.75	1.54	1.32	1.10	0.55	0.99
spleen, fetal, pool1	10044-101F8	31.78	11.28	3.42	2.30	1.59	0.32	0.56	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	9.11	2.59	1.24	0.52	0.21	0.21	0.10	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.92	2.28	0.57	0.00	0.19	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	9.44	5.94	1.75	0.00	0.35	0.00	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	4.30	2.74	1.17	0.39	0.39	0.00	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	5.29	2.48	0.00	0.11	0.11	0.23	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	1.27	0.42	0.42	0.00	0.42	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	25.81	5.08	2.12	0.42	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	18.16	6.41	3.20	2.14	2.14	1.07	1.07	1.07
submaxillary gland, adult	10202-103F4	25.64	6.27	3.99	0.00	0.57	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.07	6.02	2.28	3.74	1.04	0.42	0.62	0.21
substantia nigra, adult, donor10258	10371-105G2	17.07	13.97	1.55	1.03	2.07	0.52	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	7.07	12.72	1.41	1.41	2.12	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	15.59	2.75	1.60	1.60	0.46	0.46	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	27.55	24.92	3.81	4.32	2.20	3.31	3.05	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.21	16.38	13.53	2.85	0.71	2.14	3.56	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	83.95	23.74	10.11	5.71	2.20	4.40	2.20	0.44
tenocyte, donor1	11763-123H8	11.17	3.14	0.70	0.35	1.05	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	6.49	1.91	0.00	0.00	0.00	0.76	0.00	0.00
tenocyte, donor3	11768-123I4	5.19	1.11	0.74	0.74	0.00	0.00	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	9.01	6.46	0.85	0.17	0.00	0.17	0.68	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	13.26	5.70	0.31	0.92	0.46	0.31	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	6.82	3.87	0.77	0.31	0.31	0.31	0.00	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	10.92	17.52	1.40	0.76	0.76	0.51	1.65	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	29.50	2.27	0.38	0.00	0.00	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	15.70	13.85	1.31	1.09	0.98	0.33	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	9.45	34.52	1.63	0.00	0.00	0.65	1.30	0.33
testis, adult, pool1	10026-101D8	35.43	12.88	2.15	2.47	1.72	2.25	1.61	0.43
testis, adult, pool2	10096-102C6	13.53	22.55	1.80	2.26	0.90	3.61	1.80	0.00
thalamus - adult, donor10196	10168-103B6	24.29	16.56	2.21	1.10	2.21	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	24.38	10.00	2.19	1.72	0.47	0.31	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	12.32	0.00	1.54	1.54	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.36	11.53	0.82	0.99	0.16	1.65	1.98	0.66
thalamus, newborn, donor10223	10366-105F6	19.56	12.66	1.73	2.30	2.30	2.30	1.73	0.00
throat, adult	10209-103G2	26.22	9.24	2.50	0.50	0.75	2.50	0.25	0.00
throat, fetal, donor1	10061-101H7	19.20	13.10	3.66	1.22	0.30	0.30	0.91	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	7.15	3.58	0.79	0.00	0.20	0.00	0.20	0.20
thymus, adult, pool1	10027-101D9	8.65	12.53	2.19	0.89	0.20	0.50	0.89	0.89
thymus, fetal, pool1	10043-101F7	21.61	16.21	2.60	1.25	0.73	0.31	1.14	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	9.31	3.32	0.66	0.13	0.27	0.27	0.00	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	5.45	1.54	0.84	0.42	0.28	0.28	0.14	0.28
thyroid, adult, pool1	10028-101E1	43.76	5.51	3.45	1.68	1.49	0.65	0.56	0.28
thyroid, fetal, donor1	10060-101H6	14.24	12.13	3.16	0.79	1.05	0.53	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	21.56	6.16	0.00	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	20.23	5.81	1.40	1.16	0.47	0.70	0.47	0.23
tongue, fetal, donor1	10059-101H5	13.40	6.70	2.76	1.97	0.39	0.00	0.00	0.79
tonsil, adult, pool1	10047-101G2	19.53	7.61	2.10	1.30	0.70	0.20	0.40	0.10
trachea, adult, pool1	10029-101E2	33.29	6.95	2.21	2.62	1.23	0.90	0.57	0.08
trachea, fetal, donor1	10058-101H4	21.93	5.00	3.08	3.46	0.77	1.15	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	11.34	2.48	0.35	1.06	1.06	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.36	1.72	1.01	0.00	0.61	0.30	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	5.95	6.42	0.47	0.16	0.00	0.47	0.47	0.16
tridermal teratoma cell line:HGRT	10694-109G1	24.73	7.61	1.90	0.00	3.81	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	13.12	3.64	1.35	0.93	0.34	0.08	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	20.87	2.09	0.00	2.09	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	37.20	16.04	4.95	4.44	1.71	1.54	0.34	0.34
uterus, fetal, donor1	10055-101H1	40.95	6.14	5.12	2.05	1.02	1.02	1.54	2.05
vagina, adult	10204-103F6	61.39	7.75	3.23	1.29	1.29	1.94	0.00	0.00
vein, adult	10191-103E2	19.07	10.74	1.53	1.10	1.53	1.32	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	5.87	1.34	0.80	0.27	0.00	0.53	0.00	0.00